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INTRODUCTION 
Hepatotoxicity implies chemical-driven liver damage. Certain medicinal 
agents, when taken in overdoses and sometimes even when introduced within 
therapeutic ranges, may injure the organ. (Figure 1) Other chemical agents, such as 
those used in laboratories and industries, natural chemicals (e.g., microcystins) and 
herbal remedies can also induce hepatotoxicity. Chemicals that cause liver injury are 
called hepatotoxins or hepatotoxicants1. 
Hepatotoxicants are exogenous compounds of clinical relevance and may 
include overdoses of certain medicinal drugs, industrial chemicals and natural 
chemicals like microcystins, herbal remedies and dietary supplements.  More than 
900 drugs have been known to cause liver injury. Many drugs have been withdrawn 
from the market after it was found to be toxic to the liver. Many chemicals cause 
subclinical injury to liver whichmanifests only as abnormal liver enzyme tests. 
Druginduced liver injury is responsible for 5% of all hospital admissions and 50% of 
all acute liver failures. More than 75 percent of cases of idiosyncratic drug reactions 
result in liver transplantation or death. 
Figure 1: Hepatotoxicity 
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LIVER 
Liver is the largest organ of the human body weighing about 1500 g, and is 
located in the upper right corner of the abdomen on top of the stomach, right kidney 
and intestines and beneath the diaphragm2.  
Functions of liver:  
• Synthesis of products like glucose derived from glycogenesis, plasma proteins, 
clotting factors and urea that are released into the bloodstream.  
• Regulates blood levels of amino acids. 
• Liver parenchyma serves as a storage organ for several products like glycogen, 
fat and fat soluble vitamins.  
• Liver isinvolved in the production of bile that aids in the removal of toxic 
substances and serves as a filter that separates out harmful substances from the 
bloodstream and excretes them.  
• Smooth endoplasmic reticulum of the liver is the ‘clearing house’ for both 
endogenous chemicals like cholesterol, steroid hormones, fatty acids and 
proteins, and exogenous substances like drugs and alcohol.  
The central role played by liver in the clearance and transformation of chemicals 
exposes it to toxic injury. 
INTERNAL ANATOMY OF LIVER3 
The liver is a large organ, possessing distinct lobes, and lies in the anterior 
right portion of the abdominal cavity in close association with the diaphragm and the 
stomach. (Figure 2) 
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Internally, the liver is composed of large number of lobules, which are 
morphologically identical and separated from each other by a sheet of connective 
tissue. 
The liver has a copious and extensive blood supply and is particular in that it 
has two major afferent vessels supplying it with blood. These are the portal veins, 
which are the main supplier and transports food materials absorbed from the 
intestines to the liver where they can be ‘processed’ and the hepatic artery, supplies 
the liver tissues with oxygen. Both vessels give off branches, which supply blood to 
the sinusoids of the structural lobule.  
 
Figure 2: Internal anatomy of liver 
The hepatic cells comprising a structural lobule from a continuous cellular 
network permeated by tunnels in which the sinusoids run. The wall of the sinusoids 
are externally delicate, allowing intimate contact between blood and the hepatic 
cells, and at intervals along the sinusoids are found small flattened 
reticuloendothelial cell known as Kupffer cells which have a phagocyte function. 
Chapter 1 Introduction 
Dept. of Pharmacology 4 JKK Nattraja College of Pharmacy 
Minute bile canaliculated run between adjacent hepatic parenchyma cells, draining 
away the bile produced by them into bile ducts. 
BIOTRANSFORMATION  
The liver plays an important role in the metabolism and biotransformation of 
substances. The liver protects the body from harmful toxins and foreign chemicals in 
association with the small intestine and the systemic circulation.The liver may be 
exposed to large concentrations of exogenous substances and their metabolites. 
Metabolism of exogenous compounds can modulate the properties of hepatotoxicant 
by either increasing its toxicity or decreasing its toxicity (detoxification). Most of 
the foreign substances are lipophilic or fat soluble thus enabling them to cross the 
membranes of intestinal cells. They are rendered more water soluble by biochemical 
processes in the liver cells. These water soluble products are exported into plasma or 
bile by transport proteins located on the hepatocyte membrane and subsequently 
excreted by the kidney or gastrointestinal tract. 
The hepatic biotransformation involves Phase I and Phase II reactions(Figure 
3). Phase I involves oxidative, reductive, hydroxylation and demethylation 
pathways. The cytochrome P-450 enzyme system located in the endoplasmic 
reticulumis the most important family of metabolizing enzymes in the liver. The 
endoplasmic reticulum also contains a NADPH-dependent mixed function oxidase 
system, the flavin-containing monooxygenases, which oxidizes amines and sulphur 
compounds. Phase I reactions often produce toxic intermediates which are converted 
into non-toxic metabolites by phase II reactions4. 
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Phase II reactions involve the conjugation of chemicals with hydrophilic 
groups such as glucuronide, sulfate or amino acids and lead to the formation of more 
water-soluble metabolites that can be excreted easily. Another Phase II reaction 
involves glutathione which can covalently bind to toxic intermediates. Hence, these 
reactions are usually considered detoxification pathways. However, this phase can 
also lead to the formation of unstable precursors to reactive species that can cause 
hepatotoxicity. 
The activities of enzymes are influenced by various factors and exogenous 
drugs or chemicals. Many substances can influence the cytochrome P450 enzyme 
mechanism. Such substances can serve either as inhibitors or inducers. Enzyme 
inhibitors act immediately by blocking the metabolic activity of one or several 
cytochrome P450 enzymes. Enzyme inducers act slowly and increase cytochrome 
P450 activity by increasing its synthesis. Certain substances may share the same 
cytochrome P450 specificity, thus competitively block their biotransformation 
activity and lead to accumulation of drugs metabolized by the enzyme. Genetic 
variations or polymorphisms in cytochrome P450 metabolism may also be 
responsible for unusual sensitivity or resistance to drug effects at normal doses 
among different individuals. Hepatotoxicity may also arise from an adaptive 
immune response to proteins bound to the hepatotoxicant or its metabolites. Random 
exposure to lipopolysaccharides (LPS) or other inflammatory conditions could also 
potentiate hepatotoxicity. 
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Figure 3: Metabolic Pathway of Liver 
 
Metabolic pathways vary in enzyme expression and substrate specificity in 
species, strain or gender. Hepatotoxic effect of acetaminophen differs in different 
species. For instance, hamsters and mice are sensitive to the hepatotoxic effects of 
acetaminophen whereas rats and humans appear to be resistant. This is mainly due to 
differences in the rate of production of toxic metabolite of acetaminophen, N-acetyl-
p-benzoquinoneimine (NABQI). However, isolated hepatocytes from all the four 
species are equally susceptible to the toxic effects of NABQI. Well- nourished 
animals have increased concentration of cofactors like NADPH and glutathione that 
protect the liver.Fed rats are relatively resistant to the hepatotoxic effects of 
bromobenzene and acetaminophen whereas depriving them of food overnight makes 
them extremely susceptible to these hepatotoxicants. 
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BIOCHEMICAL MARKERS 
The hepatotoxins produce a wide variety of clinical and histopathological 
indicators of hepatic injury. (Figure 4) Liver injury can be diagnosed by certain 
biochemical markers or liver enzymes like alanine aminotransferase [ALT], 
aspartate aminotransferase [AST], alkaline phosphatase [ALP] and bilirubin5. 
Elevations in serum enzyme levels are clear indicators of liver toxicity whereas 
increases in both total and conjugated bilirubin levels are measures of overall liver 
function. An elevation in transaminase levels in conjunction with a rise in bilirubin 
level to more than double its normal upper level, is considered as an ominous marker 
for hepatotoxicity. Hepatotoxicity is confirmed after macroscopic and 
histopathological observations and investigation of additional clinical biochemistry 
parameters are completed. 
The ratio ALT: ALP helps in deciding the type of liver damage by 
hepatotoxins. The ratio ALT: ALP is greater than or equal to five during 
hepatocellular damage. It is less than or equal to two during cholestatic liver 
damage. During mixed type of liver damage, the ratio ranges between two and five. 
ALT and AST or in combination with total bilirubin are primarily recommended for 
the assessment of hepatocellular injury in rodents and non-rodents in non-clinical 
studies. ALT is considered a more specific and sensitive indicator of hepatocellular 
injury than AST6. 
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DRUG INDUCED LIVER TOXICITY
Drugs can cause toxicity of liver due to various factors.
1. Age and gender
2. Genetic factorsand idiosyncrasies. (Figur
3. Dose and duration of drugs
4. Kidney damage
5. Alcohol and cigarette smoke
6. Drug-drug interactions
7. Diseases such as HIV, Hepatitis C, Rheumatoid Arthritis, Systemic Lupus 
Erythematosus
8. Obesity and nutritional status
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Figure 4: Patterns of liver injury 
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Figure 5: Categories of Hepatotoxicity
TYPES OF DRUG INDUCED HEPATOTOXICITY
Hepatotoxicity can be broadly divided into two main groups, each with a 
different mechanism of injury: hepatocellular and cholestatic. (Figure 5)
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PARACETAMOL 
Paracetamol or acetaminophen is an active metabolite of phenacetin9. It is 
well tolerated, lacks many of the side effects of aspirin and is available over-the-
counter, so it is commonly used for the relief of fever, headache and other minor 
aches and pains. Paracetamol is also useful in the management of more severe pains, 
where it allows lower dosages of additional Non-Steroidal Anti-Inflammatory Drugs 
(NSAIDs) or opioid analgesics to be used, thereby minimizing overall side-effects. It 
is a major ingredient in numerous cold and flu medications. 
Paracetamol is considered a safe drug at normal human doses. However it 
can be fatal if overdosed. Paracetamol doses exceeding 150 mg/kg are considered 
hepatotoxic. 
PARACETAMOL METABOLISM 
Paracetamol is metabolized in the liver via three pathways; glucuronidation, 
sulfation or via the hepatic cytochrome P450 enzyme system, which is responsible 
for the toxic effects of Paracetamol due to alkylating metabolite N-acetyl-P-benzo-
quinone imine (NAPQI) [9]. (Figure 7) In this pathway, Paracetamol is converted to 
a metabolite which is toxic to liver cells. Glutathione (a tripeptide) then binds to this 
toxic metabolite resulting in a non-toxic compound. Hepatotoxicity occurs when 
glutathione stores are depleted faster than they can be regenerated and the toxic 
metabolite is left to accumulate. The metabolism of Paracetamol is an excellent 
example of intoxication. 
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Figure 7: Metabolic pathway of Paracetamol 
RISK FACTORS FOR PARACETAMOL TOXICITY 
Use of P450 2E1 inducing drugs egphenobarbitone, carbamazepine.  
Induction of the P450 2E1 iso-enzyme leads to increased conversion of paracetamol 
to its toxic metabolite NAPQI10.  
• Malnourishment, fasting, acute or chronic illness Recent significant fasting or 
illness, such as eating disorders (eg. Anorexia nervosa), or chronic illness such 
as HIV/AIDS may reduce intracellular glutathione levels increasing toxicity of 
NAPQI 
• Chronic alcoholism Alcohol consumption at these levels may both induce iso-
enzyme P450 2E1 and reduce intracellular glutathione stores  
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• Gilbert’s syndrome, Crigler
defects may be at greater risk of paracetamol toxicity
Activated charcoal seems the best choice to reduce absorption. No N
acetylcysteine regime has been shown to be more
transplantation may be life
THIOACETAMIDE 
THIOACETAMIDE is a crystalline compound used as a laboratory reagent 
in place of Hydrogen sulphide
Thioacetamide
in water and ethanol. Thioacetamide is currently only used as a replacement for 
hydrogen sulfide in qualitative analysis. When heated to decomposition, it emits 
toxic fumes of nitrogen oxides and
human exposure to thioacetamide are inhalation and dermal contact. It is reasonably 
anticipated to be a human carcinogen. (NCI05)
white crystals with a mercaptan odor.
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-Najjar syndrome Individuals suffering these genetic 
 
 effective than any other. 
-saving for patients with poor prognosis.
. ( Figure 8) It is a potent hepatocarcinogen.
 
(Figure 8: structure of Thioacetamide) 
 (TAA) is a synthetic, colorless crystalline solid that is soluble 
 sulfur oxides. The primary routes of potential 
. Thioacetamide is in the form of 
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Figure 9 : Mechanism of action of Thioacetamide in liver 
Thioacetamide is a potent centrilobularhepatotoxicant, which undergoes a 
two-step bioactivation mediated by microsomal CYP2E1 to thioacetamide 
sulphoxide (TASO), and further to a reactive metabolite thioacetamide-S, S-dioxide 
(TASO2)  
STUDY MODELS OF HEPATOTOXICITY 
IN VIVO SYSTEMS 
Animal models represent a major tool for the study of mechanisms in 
virtually all of biomedical research. Both small animals like rats, mice, rabbits and 
guinea pigs as well as large animals like pigs, cattle, sheep and monkeys are useful 
and reliable for studying the hepatotoxicant effects12, distribution and clearance. 
Thioacetamide (TAA) administration is an established technique for generating rat 
models of liver fibrosis and cirrhosis. 
IN VITRO SYSTEMS 
Chemical hepatotoxicity can be studied using six in vitro experimental 
systems, namely, isolated perfused liver preparations, liver slices, isolated 
hepatocytes in suspension, isolated hepatocytes culture and co-culture, cell lines and 
subcellular fractions. 
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HERBAL REMEDIES FOR LIVER TOXICITY 
Herbal drugs have been used in the treatment of diseases since ancient times.  
They have been widely used traditionally in developing and developed countries 
owing to its natural origin and lesser side effects or inability to bear the results of 
synthetic drugs. The uses of traditional medicines are widely spread and plants 
represent a large source of natural chemicals that might serve as leads for the 
development of the novel drugs. 
HISTORY OF PLANT MEDICINE 
The earliest recorded evidence of their use in Indian, Chinese, Egyptian, 
Greek, Roman and Syrian texts dates back to about 5000 years. Ancient Chinese and 
Egyptian papyrus writings describe medicinal uses for plants as early as 3,000 BC13. 
Indigenous cultures (such as African and Native American) used herbs in their 
healing rituals. The herbal medicines/traditional medicaments have, therefore, been 
derived from rich traditions of ancient civilizations and scientific heritage.  
Ayurveda14 is a medical system primarily practiced in India. It includes diet 
and herbal remedies, while emphasizing the body, mind and spirit in disease 
prevention and treatment (Morgan, 2002). 
The World Health Organization (WHO) has recently defined traditional 
medicine (including herbal drugs) as comprising therapeutic practices that have been 
in existence, often for hundreds of years, before the development and spread of 
modern medicine and are still in use today15. The traditional preparations comprise 
medicinal plants, minerals, organic matter, etc. Herbal drugs constitute only those 
traditional medicines which primarily use medicinal plant preparations for therapy. 
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MEDICINAL PLANTS OF INDIA 
India has a very long, safe and continuous usage of many herbal drugs in the 
officially recognized alternative systems of health viz. Ayurveda, Yoga, Unani, 
Siddha, Homeopathy and Naturopathy. These systems have rightfully existed side-
by-side with Allopathy.  Millions of Indians use herbal drugs regularly, as spices, 
home-remedies, health foods as well as over-the-counter (OTC) as self-medication 
or also as drugs prescribed in the non-allopathic systems.  
There are about 45,000 plant species in India, with concentrated hotspots in 
the region of Eastern Himalayas, Western Ghats and Andaman & Nicobar Island. 
The officially documented plants with medicinal potential are 3000 but traditional 
practitioners use more than 6000. India is the largest producer of medicinal herbs 
and is appropriately called the botanical garden of the world. Medicinal plants 
continue to provide valuable therapeutic agents, both in modern medicine and in 
traditional systems of medicine.  
HERBAL REMEDIES FOR LIVER DISEASES 
Allopathic drugs are inadequate to treat liver diseases and a variety of liver 
dysfunctions as statistics show. So a lot of research has been done on herbs that are 
claimed to possess hepato-protective activities. Major liver diseases are treated with 
many herbal drugs.  
Silymarin 
Silymarin is a herb obtained from the herbal plant, ‘milk thistle’ 
(Silybummarianum). The active ingredients of the plant are obtained from the dried 
Chapter 1 Introduction 
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seeds; Silymarin is one of the herbal medicines that have been extensively studied, 
both clinically and chemically, for the treatment of major liver diseases16.  
Silybin, which is the most active compound of Silymarin, is the major 
contributor of the hepato-protectiveness of the medicine. Silymarin is a drug which 
is taken orally and is mainly excreted through the bile. It has been claimed that 
silymarin has clinical applications in the treatment of toxic hepatitis, fatty liver, 
cirrhosis, ischaemic injury, radiation toxicity and viral hepatitis as a result of its 
antioxidative, anti-lipid-peroxidative, antifibrotic, anti-inflammatory, immune 
modulating, and even liver regenerating effects. Though silymarin does not have 
antiviral properties against hepatitis viruses, it promotes protein synthesis, helps in 
regenerating liver tissue, controls inflammation, enhances glucuronidation and 
protects against glutathione depletion. 
In liver diseases caused by oxidative stress (alcoholic and non-alcoholic fatty 
liver and steatohepatitis, drug- and chemically-induced hepatic toxicity), the 
antioxidant medicine Silymarin is the primary therapeutic modality of choice. 
Numerous reports have noted the benefits of Silymarin, not only as a treatment for 
chronic liver diseases, but also in viral-induced chronic hepatitis and primary liver 
cancer15. Several studies have identified that continuous usage of Silymarin has 
significantly proved to increase the survival time of patients with alcohol-induced 
liver cirrhosis. 
Liv-52 
An Ayurvedic supplement, recognized and registered in more than 45 
countries, and a well-known herb prescribed by many physicians worldwide. Liv-52 
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is available as tablets and syrup containing the following herbs: Capparisspinosa, 
Cichoriumintybus, Solanum nigrum, Terminalia arjuna, Cassia occidentalis, 
Achilleamillefolium, Tamarixgallica and Phyllanthus amarus17. Introduced in 1955, 
Liv-52 has been studied vigorously since then for the treatment of liver diseases 
such as hepatitis, alcohol liver disease, pre-cirrhotic and early cirrhosis conditions, 
elevated liver enzymes, fatty liver conditions, protein energy malnutrition, and 
radiation or chemotherapy-induced liver damage. 
Liv-52 is formulated according to Ayurvedic principles, to enhance efficacy 
and avoid toxicity. These ingredients individually and synergistically provide 
various advantageous effects, such as being an effective antioxidant, hepatic 
stimulant, carminative, stomachic and choleretic. They also help reducing anasarca 
and ascites of hepatic origin.  
CAMELLIA SINENSIS (GREEN TEA). 
Originated from and mainly produced in China and is made from the leaves 
of the plant Camellia sinensis. Apart from the use of green tea in acute liver injury 
and oxidative stress injury, green tea is proved to be useful in preventing Hepatic C 
Virus (HCV) entry into the liver cells. 18Green tea is composed of active compounds 
such as catechin, gallocatechin, epicatechin, epigallocatechin, epicatechingallate, 
and epigallocatechingallate (EGCG) in which EGCG is considered the most 
therapeutically significant compound. Studies also show that EGCG is believed to 
cause liver toxicity if taken in excess of the recommendation. Green tea is also 
documented as having stimulant effects which are believed to be due to the effect of 
some alkaloids, such as caffeine, theobromine, and theophylline. L-theanine, an 
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amino acid compound found in green tea, has been studied for its calming effects on 
the nervous system. 
GLYCYRRHIZAGLABRA (LICORICE). 
A herb that was consumed as a sweetener in food and used as an active 
component in herbal medicine. Experimental hepatitis and cirrhosis studies have 
found that it can promote the regeneration of liver cells and at the same time inhibit 
fibrosis19. Throughout the years, licorice root has been used in conventional 
medicine to treat a range of illnesses, such as bronchitis, gastritis and jaundice, 
extending from the common cold to liver disease. Licorice root is available in liquid, 
dry, powdered, and peeled form 
Glycyrrhizin inhibits liver cell injury and in Japan is given intravenously for 
the treatment of chronic viral hepatitis and cirrhosis. 
FUZHENGHUAYU (FZHY) 
The first traditional Chinese medicine compound to complete clinical studies 
in the treatment of liver diseases and has been studied carefully for its ability to heal 
liver fibrosis. FZHY is a botanical compound approved in China for liver fibrosis 
caused by hepatitis B virus infection20. 
STANDARDIZATION OF HERBAL MEDICINES 
In indigenous/traditional systems of medicine, the drugs are primarily 
dispensed as water decoction or ethanolic extract. Fresh plant parts, juice or crude 
powder are a rarity rather than a rule. Thus medicinal plant parts should be authentic 
and free from harmful materials like pesticides, heavy metals, microbial or 
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radioactive contamination, etc. The medicinal plant is subjected to a single solvent 
extraction once or repeatedly, or water decoction or as described in ancient texts. 
The extract should then be checked for indicated biological activity in an 
experimental animal model(s). The bioactive extract should be standardized on the 
basis of active principle or major compound(s) along with fingerprints. The next 
important step is stabilization of the bioactive extract with a minimum shelf-life of 
over a year. The stabilized bioactive extract should undergo regulatory or limited 
safety studies in animals. Determination of the probable mode of action will explain 
the therapeutic profile. The safe and stable herbal extract may be marketed if its 
therapeutic use is well documented in indigenous systems of medicine, as also 
viewed by WHO. A limited clinical trial to establish its therapeutic potential would 
promote clinical use (Table 1) 
To ensure the quality and safety of its products and practices standardization 
is of vital importance21. Most of the herbal products do not have drug regulatory 
approval to demonstrate their safety and efficacy. The traditional use can provide 
valuable clues for the selection, preparation and indications for use of herbal 
formulation, as efficacy has been established by the common use. The historical use 
provides the source to study the specific plant species with potential to be used in a 
particular disease.  
Efficacy testing of the traditional and new herbal products in experimental 
screening method is important to establish the active component and appropriate 
extract of the plant. However, there should be adequate data from in vivo and in 
vitro studies to validate the therapeutic potential claimed. There is a need to 
establish the pharmacological activities for identifying and comparing the various 
Chapter 1 
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preparations for potency. Animal toxicity studies are also required to establish the 
potential adverse effects.
The evaluation of new herbal products consists of six steps,  
1. Characteristics
2. History and pattern of use
3. Any adverse reacti
4. Biological action
5. To
6. Clinical trial data
Table 1: Plants investigated for hepatoprotective activity. 
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 Many research studies have been done on Bauhinia species. Including 
paracetamol induced hepatotoxicity. Bauhinia tomentosa Linn. offers promising 
results but this model is debatableand yet to be established. Therefore, an attempt has 
been made to evaluate the hepatoprotective effect of Bauhinia tomentosa Linn.using 
Paracetamol induced hepatotoxemia in mice. 
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REVIEW OF LITERATURE 
Mythreyi R et al., (2005) evaluated the antimicrobial activity of chloroform, 
methanol, ethanol, petroleum ether, ethyl acetate and aqueous extract of dried leaves 
of Bauhinia tomentosaLinn.against Bacillus cereus, Bacillus subtilis, Escherichia 
coli, Pseudomonas aeruginosa, Staphylococcus aureus, Candida albicans and 
Aspergillus niger by cup-plate method. Methanol extract (100 µg) of Bauhinia 
tomentosaLinn.has shown significant activity against the tested microorganisms in 
comparison with the standard doxycycline and ketoconazole. Each 100 mg of 
chloroform and ethanol extract of Bauhinia tomentosaLinn also showed 
antimicrobial activity against tested organisms whereas no other extracts show such 
activity28. 
Aderogba MA et al., reported the antioxidant constituents of Bauhinia 
tomentosa L. (Fabaceae). An activity-guided fractionation procedure was used to 
identify the antioxidative constituents of the 50% ethanol dried leaves extract of 
Bauhinia tomentosaLinn. Four flavonol glycosides: kaempferol-7-o-rhamnoside, 
kaemperol-3-o-glucoside, quercetin-3-o-glucosides and quercetin-3-o-rutinoside 
were isolated using chromatographic techniques. The structures of the compounds 
were established by spectroscopic methods: H1, C13 NMR and mass spectra 
techniques. ABTS and DPPH spectrometric techniques were comparatively 
employed to evaluate the antioxidant activity of the isolated compounds for novel 
antioxidant agents from natural sources. All the compounds exhibited considerable 
antioxidant activity29. 
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Johnson O.Agbede., (2007) examined the chemical analysis of leaf meal 
and processed seed flours of an aesthetic plant: Bauhinia tomentosaLinn. The leaf 
meal and differently processed seed flours of an aesthetic plant Bauhinia 
tomentosaLinn were assessed for their nutritional potential in animal feeding. The 
leaf meal (LM) and the differently processed seed flours were analyzed for their 
proximate composition, gross energy, amino acid profile and the anti-nutrients. The 
leaf meal contained crude protein (CP) 112.0 g/Kg DM and 14.9 MJ/Kg gross 
energy (GE).  It was concluded that the leaf meal as well as the seed flours from 
processed Bauhinia tomentosaLinn.apart from its aesthetic value could be used as 
animal feeding material30. 
Buchholz et al., (2004) evaluated the hypoglycaemic activity of the plant 
extracts from Bauhinia species in the treatment of type 2 diabetes. Bauhinia 
tomentosaLinn.was also included as one among the species. The extracts, when 
applied to rats according to the N0-STZ Rat model, decreases the fasting Plasma 
Glucose Concentration versus initial Basal glycemia significantly. The extracts were 
also decreases the area under the curve - Plasma Glucose Concentration versus time 
in the Oral Glucose Tolerance test31.  
Kumar., et al., (2006) investigated central nervous system (CNS) activity of 
the methanol extracts of leaves of Caesalpiniabonducella (MECB) and stem bark of 
Bauhinia racemosa (MEBR) (Caesalpinaceae) in Swiss albino mice and Wistar 
albino rats. General behavior, exploratory behavior, muscle relaxant activity and 
phenobarbitone sodium-induced sleeping time were studied. The results revealed 
that the methanol extracts of leaves of Caesalpiniabonducella at 100 - 200 mg/kg 
and stem bark of Bauhinia racemosa 100 - 200 mg/kg caused a significant reduction 
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in the spontaneous activity (general behavioral profile), remarkable decrease in 
exploratory behavioral pattern (Y-maze and head dip test), a reduction in muscle 
relaxant activity (rotarod and traction tests), and also significantly potentiated 
phenobarbitone sodium-induced sleeping time. The results suggest that MECB and 
MEBR exhibit CNS depressant activity in tested animal models32. 
Kannan., et al (2013) investigated evaluate the ameliorative effect of 
Bauhinia tomentosaLinn. during ulcerative colitis (UC). Three groups of animals 
(n = 6) were treated with B. tomentosa (5, 10, 20 mg/kg B.wt respectively) for 5 
consecutive days before induction of UC. UC was induced by intracolonic injection 
of 3% acetic acid. The colonic mucosal injury was assessed by macroscopic scoring 
and histological examination. Furthermore, the mucosal content of lipid peroxidation 
(LPO), reduced glutathione (GSH), nitric oxide (NO), glutathione peroxidase (GPx) 
and superoxide dismutase (SOD) activity confirms that B. tomentosaLinn. could 
significantly inhibit colitis in a dose dependent manner. The myeloperoxidase 
(MPO), tumor necrosis factor (TNF-α), inducible nitric oxide synthase (iNOS) 
expression studies and lactate dehydrogenase (LDH) assay also supported that B. 
tomentosa could significantly inhibit experimental colitis. The effect was 
comparable to the standard drug sulfasalazine. Colonic mucosal injury parallels with 
the result of histological and biochemical evaluations. The extracts obtained from B. 
tomentosaLinn. possess active substances, which exert marked protective effects in 
acute experimental colitis, possibly by regulating the antioxidant and inflammatory 
mediators33. 
Solomon., et al (2016) investigated the Anti-cancer activity of Bauhinia 
tomentosa (Flowers) against human liver cancer . The MTT assay of the compound 
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isolated from the ethyl acetate fraction of flowers of Bauhinia tomentosa shows that 
all concentrations are having anticancer activity. The sample concentrations of 
1000µg/ml, 500 µg/ml, 250µg/ml, 125µg/ml and 62.5µg/ml show 65.14 µg/ml, 
52.03 µg/ml, 40.87 µg/ml, 36.54 µg/ml, 25.63 µg/ml CTC50 value against the 
human liver cancer HePG2 cell line respectively. Thus B. tomentosa L. flowers to 
have the potential to act as a source of useful anticancer drugs and also to improve 
the health status. Further work is required in order to establish the identity of the 
chemical component responsible for anticancer activity34. 
Narayanan., et al (2013)evaluated the ameliorative effect of Bauhinia 
tomentosa during ulcerative colitis (UC). Three groups of animals (n = 6) were 
treated with B. tomentosaL.(5, 10, 20 mg/kg B.wt respectively) for 5 consecutive 
days before induction of UC. UC was induced by intracolonic injection of 3% acetic 
acid. The mucosal content of lipid peroxidation (LPO), reduced glutathione (GSH), 
nitric oxide (NO), glutathione peroxidase (GPx) and superoxide dismutase (SOD) 
activity confirms that B. tomentosaLinn.could significantly inhibit colitis in a dose 
dependent manner. The myeloperoxidase (MPO), tumor necrosis factor (TNF-α), 
inducible nitric oxide synthase (iNOS) expression studies and lactate dehydrogenase 
(LDH) assay also supported that B. tomentosaLinn. could significantly inhibit 
experimental colitis. The effect was comparable to the standard drug sulfasalazine. 
The extracts obtained from B. tomentosaLinn. possess active substances, which exert 
marked protective effects in acute experimental colitis, possibly by regulating the 
antioxidant and inflammatory mediators35. 
Mukundan., et al  investigated  simple, cost effective, non-toxic gold 
nanoparticles (AuNP) synthesized using leaves extract of Bauhinia tomentosa Linn 
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and it’s invitro anticancer activity. The in-vitro anticancer activity confirmed by 
MTT assay on the cell lines of laryngeal HEp-2 carcinoma cells showed IC50 values 
of extract at 53.125 µg/mL and AuNP’s at 34.375 µg/mL. The AuNP’s inhibited the 
proliferation of HEp-2 cells in a dose and time dependent manner. The IC50 value of 
AuNP showed that the concentration required to inhibit 50% of HEp-2 cells was less 
than that of B.tomentosaLinn. leaves extract36. 
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AIM AND OBJECTIVE 
Hepatotoxicity is a major pharmacological effect of drugs and has been an 
important reason for the withdrawal and banning of many drugs in the market. It is 
also a significant contributor of drug interactions on account of its playing a major 
role in the metabolism and biotransformation of drugs and other substances that 
enter the body.  A significant amount of deaths occur due to diseases aggravated by 
the toxic action of therapeutic substances on the liver. 
There are not many measures to combat the hepatotoxicity of drugs except 
for reducing the dose, stopping the drug suspected to be responsible and changing 
the drugs substituting it with another drug of the same pharmacological action. The 
damage is either permanent or temporary depending on various factors like age, 
race, sex, underlying medical illnesses, drug interactions etc.  
In this study, we are looking into herbal compounds that may help offer 
protection from the toxic effects of paracetamol and thioacetamide on the liver of 
animals.  
Paracetamol is a commonly used NSAID. It is safe in prescribed doses but 
toxic in higher dosages. Paracetamol poisoning is treated currently with N-Acetyl 
cysteine but the treatment profile is largely unclear as we have seen in literature. In 
cases of poor prognosis, liver transplant could be the only option.  It is expensive 
and the outcome may or may not be favorable. Thioacetamide is a known 
hepatocarcinogen.  Its toxicity in animal studies is well documented.  
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This situation warrants us to explore other remedies for treating 
hepatotoxicity. The plant kingdom has lots of known and unknown plants with 
hepatoprotective properties.  
Plant extracts have a wide range of medicinal actions, and throughout 
history, they have been used to treat many different types of diseases. In the 
treatment of many diseases, antioxidant therapy plays a key role, so current research 
is now directed towards finding naturally occurring hepatoprotectiveof plant origin. 
In Indian system of medicine, the plant BauhiniatomentosaLinnis being used 
to treat many illnesses, successfully. The medicinal properties of this plant may be 
due to the presence of phytochemicals like tannins, flavonoids, terpenoids and 
steroids. Presently it has become a source of medicine for healing human and animal 
diseases.  
Hence, in order to contribute further to the knowledge of Indian traditional 
medicine, and its rich history, the objective of the present study is to subject the 
traditionally well-known plant Bauhinia tomentosa Linn. It was decided to extract 
the whole plant using suitable solvents and the dried extract will be used to evaluate 
the possible hepatoprotective effect of Bauhinia tomentosaLinn.in albino mice. 
SPECIFIC OBJECTIVE: 
 To elucidate the possible liver protective mechanism of action of Bauhinia 
tomentosa L. extract. 
 To screen preliminary phytochemicals of ethanol extract of 
BauniniatomentosaL. 
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 To study the effect of the extract of Bauhinia tomentosa Linn on paracetamol 
and thioacetamide induced hepatotoxicity in albino mice using liver enzymes 
as biomarkers. 
 To study the effect of the ethanolic extract of Bauhinia tomentosa Linn. on 
serum bilirubin, in paracetamol and thioacetamide induced hepatotoxicity 
 To observe suppression of inflammation and cell recovery after 
administration of various concentrations of the extract. 
 To screen for anti- oxidant potential of the Bauhinia tomentosa Linn. using 
enzymatic (SOD, CAT, GPx)  and non- enzymatic methods (GSH).  
 To assess the free radical scavenging potential of Bauhinia tomentosa Linn. 
using Lipid peroxidase test (LPO) 
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Plant Name : Bauhinia tomentosa
Figure 10    Flower of 
Botanical information:
Kingdom : Plantae
Phylum          : Magnoliophyta
Class              : Magnoliopsida
Order             : Fabales
Family        : Caesalpiniaceae
Subfamily     : Caesalpinioideae
Tribe           : Cercideae
Genus         : Bauhinia
Species           : tomentosa
Botanical name : Bauhinia tomentosa
Vernacular names : 
Sanskrit : Aswamantaka
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Hindi : Kachnar 
Bengali : Kanchan 
Unani : Kachnal 
Tamil   : Tiruvatti, Kokku mandarai 
Telugu    : Avadimandaramu 
Malayalam : Kanchanapu, Kokkumandara 
Habitat: 
Bauhinia is deciduous, but can be evergreen in a mild climate25.  The specie 
name “tomentosa” means hairy and it refers to the velvety/hairy Pods. Bauhinia is a 
genus of more than 300 species of flowering plants in the sub family 
Cesalpinioideae of the large flowering plant family Fabaceae, with a pantropical 
distribution. These plants can be found along the coastal strip from southern 
Kwazulu-Natal to Maputoland, Mpumalanga as well as Mozambique, Zimbabwe, 
tropical Africa and as far as India and Srilanka.   
Parts used: 
The whole plant, root, bark, flowers, leaves, buds, young seeds and fruit. 
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Figure 11: Bauhinia tomentosa Linn. 
Morphological characters: 
Medium to large shrub to a small tree, up to 4m in height. Leaves are divided 
into two lobes, light green in color, with a leathery texture, carried on branches that 
are often drooping. It produces large bell-shaped, bright yellow flowers(figure 10) 
with a black to deep maroon colored center from December to March. The fruit are 
pea like, slender and velvety. They are light green, turning a pale brown with age 
and are produced from January to June or even later. Bark is gray or brown25. (figure 
11) 
Chemical constituents:  
Constituents 
- Flower contains flavonoids, isoquerlitrin 6%, rutin 4.6%, and a small amount 
of quercetrin. 
- Flower extract yielded lignins, saponins, sterols, alkaloids, and phenols. 
- Seed yields a fatty oil, called ebony oil, protein, pentosan, water soluble 
mucilage and saponins. 
- Bark yields a fiber. 
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- Phytochemical screening of crude extract of flowers yielded carbohydrates, 
glycosides, alkaloids, phytosteroids, flavonoids, saponins, tannins, phenolic 
compounds, and fixed oils. 
- Roots yielded glycosides, proteins, flavonoids, carbohydrates, tannins and 
phenolic compounds, and steroids26.  
Medicinal properties and uses:  
Decoction of the root bark is useful in inflammation of the liver and as a 
vermifuge. Buds and young flowers are prescribed in dysenteric affections. Bruised 
bark ground with rice water made into a paste is applied externally to tumours and 
wounds such as scrofulous. Fruit is diuretic. Plant used in snake bite and scorpion 
sting. The seeds are tonic and aphrodisiac. This plant is also known to be digestive, 
antibacterial, antioxidant, antifungal, anthelmintic, and stomachic27.          
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MATERIALS AND METHODS 
PHARMACOGNOSTIC STUDIES OF ETHANOLIC EXTRACT OF 
Bauhinia tomentosaLinn. 
COLLECTION AND AUTHENTICATION OF PLANT MATERIALS 
Fresh leaves of Bauhinia tomentosa L. were collected locally from 
Tamilnadu, India and authenticated by P.Satyanarayana, scientist, Botanical survey 
of India (BSI), Coimbatore, Tamil Nadu. Leaves were separated from adulterants, 
shade dried and powdered coarsely. Paracetamol drug (Sun Pharmaceuticals Ltd) 
purchased from local medical store. All reagents procured were analytical grade. 
EXTRACTION OF PLANT MATERIALS 
The air dried powdered material (100 g) was taken in 1000 ml 
soxhletapparatus (figure 12)  and extracted with petroleum ether for 7 days to 
remove fatty material. At the end of 7th day the marc was taken out and it was dried 
and again subjected to extraction with absolute ethanol until the colour disappeared. 
Then the extract was concentrated by distillation. The final solution was evaporated 
to remove excess of remaining ethanol. Finally the colour consistency of ethanolic 
extract was noted37.  
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Figure 12: Soxhlet Apparatus 
PHYTOCHEMICAL EVALUATION OF ETHANOLIC EXTRACT OF 
Bauhinia tomentosaL. 
QUALITATIVE ANALYSIS 
Preliminary phytochemical analysis 
The major contributions of phytochemical studies of plant physiology are in 
determining the chemical structure and characterization of chemical compounds. In 
identifying a plant constituent, isolation of the constituent and it is necessary first to 
determine the class of compound and then to identify a particular substance with in 
that class. The class of compounds are usually clear from its response to color tests, 
solubility, Rf properties and UV spectral characteristics. However, equally 
informative data on a plant substance will be obtained from its special 
characteristics.   
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Preliminary screening is done for analysis of secondary metabolites. The 
phytochemical screening of the leaf extract was carried out37. 
TESTS FOR CARBOHYDRATES 
A small quantity of extract was dissolved separately in 5ml of distilled water and 
filtered. The filtrate was tested to detect the presence of carbohydrates. 
Molisch’s test: 
 A small amount of filtrate was treated with few drops of alcoholic α-naphthol 
solution and then 2ml of concentrated sulphuric acid was added along the sides of 
the tes tube. Appearance of purple colour or reddish violet colour ring at the junction 
of two liquids infers the presence of carbohydrates. 
Fehling’s test: 
Equal volume of Fehling’s A [copper sulphate in distilled water] and Fehling’s B 
[potassium tartarate and sodium hydroxide in distilled water] reagents were mixed 
few drops of filtrate and heated gently. Formation of brick red precipitate indicates 
the presence of reducing sugars. 
Benedict’s test: 
The filtrate was heated with few drops of Benedict’s reagent (alkaline solution 
containing cupric citrate complex). Formation of reddish brown precipitate infers the 
presence of reducing sugars. 
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Barfoed’s test: 
To a few ml of the filtrate, few drops of Barfoed’s reagent was added and 
boiled. Formation of red precipitate of copper oxide indicates the presence of 
monosaccharide. 
TEST FOR ALKALOIDS 
A small portion of the solvent free extract was stirred separately with a few 
drops of dilute hydrochloric acid and filtered. The filtrate was used for the following 
tests. 
Mayer’s test: 
To the filtrate, add few drops of Mayer’s reagent [potassium mercuric iodide 
solution]. Cream (dull white) precipitate was obtained. 
Dragendroff’s test: 
To a few ml of the filtrate, 1 ml of Dragendroff’s reagent [potassium bismuth 
iodide solution] was added. Formation of orange red precipitate indicates the 
presence of alkaloids. 
Wagner’s test: 
A small amount of filtrate was treated with Wagner’s reagent [solution of iodine 
in potassium iodide]. Reddish brown precipitate was obtained. 
Hager’s test:  
To the filtrate, few drops of Hager’s reagent were added. Yellow precipitate 
was obtained. 
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TESTS FOR GLYCOSIDES 
A small amount portion of the extract was hydrolysed with dilute hydrochloric 
acid for few hours on a water bath and the hydrolysate was tested to detect the 
presence of glycosides. 
Legal’s test: 
To the hydrolysate, 1 ml of sodium nitroprusside solution was added and it was 
made alkaline with sodium hydroxide solution. Appearance of pink to red colour 
infers the presence of glycosides. 
Borntrager’s test: 
Hydrolysate was treated with an equal volume of organic solvents [ether or 
chloroform]. The organic layer was separated, to this equal quantity of dilute 
ammonia was added. Ammoniacal layer acquires rose pink colour, infers the 
presence of glucosides. 
Killer killani test: 
Hydrolysate was dissolved in acetic acid containing trace amount of ferric 
chloride and transferred to the surface of concentrated sulphuric acid. A reddish 
brown colour was produced at the junction of two liquids gradually becames blue, 
indicates the presence of glycosides. 
TESTS FOR PROTEINS AND AMINO ACIDS 
A small quantity of extract was dissolved in a few ml of water and tested to 
detect the presence of proteins and amino acids. 
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Ninhydrin test: 
A small quantity of extract solution was boiled with 0.2% solution of Ninhydrin. 
Blue colour indicates the presence of free amino acids. 
Millon’s test: 
To the extract solution, 2ml Millon’s reagent [mercuric nitrate in nitric acid 
containing traces of nitrous acid] was added. Appearance of red colour indicates the 
presence of proteins and free amino acids. 
Biuret test: 
The extract was treated with equal volume of 40% sodium hydroxide and 2 
drops of 1% copper sulphate solution. Pink or purple colour indicates the presence 
of proteins. 
TESTS FOR PHYTOSTEROLS AND TRITERPENOIDS 
Libermann – Buchard test: 
A small quantity of extract was treated with few drops of acetic anhydride, 
followed by a few drops of concentrated sulphuric acid. A brown ring was formed at 
the junction of two layers and the upper layer turns green colour, infers the presence 
of phytosterols and formation of deep red colour indicates the presence of 
triterpenoids. 
Salkowski test: 
A small quantity of the extract was treated with chloroform and few drops of 
concentrated sulphuric acid and allowed to stand for few minutes. Red colour 
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appears at the lower layer indicates the presence of phytosterol and if it is yellow in 
colour at the lower layer indicates the presence of triterpenoids. 
Zak’s test: 
To 1 ml of the chloroform solution of the extract, mixture of glacial acetic 
acid, ferric chloride and concentrated sulphuric acid was added. Formation of purple 
colour indicates the presence of phytosterols. 
Test for Saponins 
(a) Foam Test: - The extract was diluted with 20 ml of distilled water and 
shaken in a graduated cylinder for 15 min. lengthwise. A 1 cm layer of foam 
indicates the presence of Saponins. 
(b) Lead acetate Test: - 1 ml of sample solution was treated with 1% lead acetate 
solution, formation of white precipitate indicate the presence of saponins. 
(c) Hemolytic Test: - The extract or dry powder was added one drops of blood 
placed on glass slide. If hemolytic zone appears shows the presence of 
saponins. 
 Test for Glycosides 
(a) Legal’s Test: - Dissolved the extract in pyridine and added sodium 
nitroprusside solution to make it alkaline. The formation of pink red to red 
colour shows the presence of glycosides.  
(b) Baljet Test: - 1 ml of the test extract was added with 1 ml of sodium 
picrate solution and the yellow to orange colour shows the presence of 
glycosides. 
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(c) Keller- killiani Test: - The ethanolic extract 0.5 ml of strong solution of 
lead acetate was added and filtered. The filtrate is shaken with 5 ml of 
chloroform. The chloroform layer is separated in a porcelain dish and 
removes the solvent by gentle evaporation. Dissolve the cool residue in 3 
ml of glacial acetic acid containing 2 drops of ferric chloride solution. 
Carefully transferred this solution to the surface of 2 ml of concentrated 
sulphuric acid. A reddish brown layer forms at the junction of the two 
liquids and the upper layer slowly becomes bluish green, darkening with 
standing. 
(d) Borntrager’s Test: - Added a few ml of dilute sulphuric acid to 1 ml of the 
extract solution. Boiled, filtered and extracted the filtrate with chloroform 
the chloroform layer was treated with 1 ml of ammonia. The formation of 
red colour of the ammonical layer shows the presence of anthraquinone 
glycosides. 
Test for Carbohydrates and Sugars 
(a) Molisch’s Test: - 2 ml of the extract was added with 1 ml of α- napthol 
solution was added and also added concentrated sulphuric acid though the 
side of the test tube. Reddish violet colour at the junction of the two liquids 
indicates the presence of carbohydrates. 
(b) Fehling’s Test:- 1 ml of the extract was added with equal quantities of 
Fehling solution A and B were added, upon heating formation of a brick red 
precipitate indicates the presence of reducing sugars. 
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(c) Benedict’s test: - 1 ml of extract was added with 5 ml of Benedict’s reagent, 
was added and boiled for 2 min. and cool. Formation of red precipitate 
shows presence of sugars.  
(d) Tollen’s Test: - 1 ml of extract was added with 2 ml of tollen’s reagent was 
added and boiled. A silver mirror is obtained inside the wall of the tube 
which indicates the presence of aldose sugar. 
(e) Seliwanoff’s Test: - The extract was treated with hydrochloric acid and 
resorcinol and heated. Formation of red colour shows presence of glucose. 
(f) Bromine water Test: - The little quantity of test extract, bromine water was 
added. Bromine water decolorization indicates the presence of aldose sugar. 
Test for Tannins 
(a) Gelatin Test: - 1 ml of extract was added with 1% gelatin solution 
containing 10% sodium chloride. Formation of white precipitate indicates 
the presence of tannins. 
(b) Ferric chloride Test:-1 ml of extract was added with 1 ml ferric chloride 
solution, formation of dark blue or greenish black product shows the 
presence of tannins. 
(c) Vanillin hydrochloride Test:-1 ml of extract was added with vanillin 
hydrochloride. Formation of purplish red colour indicates the presence of 
tannins. 
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(d) Lead acetate Test: - Taken a little quantity of test solution was taken and 
mixed with basic lead acetate solution. Formation of white precipitate 
indicates the presence of tannins. 
(e) A little quantity of test extract was treated with potassium ferric cyanide and 
ammonia solution. A deep red colour indicates the presence of tannins. 
(f) Potassium dichromate Test:- The sample solution was treated with 1 ml of 
10% Potassium dichromate solution gives yellowish brown precipitate 
indicate the presence of tannins. 
 Test for Flavonoids 
(a) Shinoda’s Test:- The extract solution, few fragments of magnesium ribbon 
was added and add concentrated HCL drop wise gives cherry red colour 
appears after few min., shows the presence of Flavonoids. 
(b) Alkaline reagent Test: - The extract was treated with sodium hydroxide; 
formation of yellow colour indicates the presence of Flavonoids. 
(c) Little quantity of extract was treated with lead acetate, a yellow colour 
solution formed, disappears on addition of an acid indicates the presence of 
Flavonoids. 
(d) The extract was treated with concentrated sulphuric acid, formation of 
yellow or orange colour indicates the presence of flavonoids.     
 Test for Steroids 
(a) Libermann- Burchard’s Test: - 2 ml of extract was added with chloroform 
solution, 1-2 ml of acetic anhydride and 2 drops of concentrated sulphuric 
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acid was added along the sides of the test tube. Appearance of bluish-green 
color shows the presence of steroids.  
(b) Salkowsky’s Test:-Dissolve the extract in chloroform solution, 2 ml conc. 
Sulphuric acid was added. If chloroform layer appear red color indicate the 
presence of steroids. 
 Test for Proteins and Amino acids 
(a) Biuret Test: - 1 ml of the extract was treated with 4% NaOH and few drops 
of CuSO4 solution, Formation of purple violet color indicate the presence of 
proteins. 
(b) Ninhydrin Test:- 1 ml of the extract was treated with 3 drops of 5% 
Ninhydrin solution in boiling water bath for 10 min.; formation of purplish 
or bluish color appearance indicate the presence of proteins, peptides or 
amino acid. 
(c) Xanthoproteic Test: - 1 ml of the extract was treated with 1 ml of 
concentrated nitric acid. A white precipitate formed, it was boiled and 
cooled. Then 20% of sodium hydroxide or ammonia is added. Orange color 
indicates the presence of amino acids. 
(d) Millon’s Test: - 1 ml of the extract was treated with millon’s reagent 
(mercuric nitrate in HNO3) white precipitate turns to brick red indicates the 
presence of proteins.  
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Test for Triterpenoids 
Knoller’s Test: - Dissolved 2 or 3 granules of tin metal in 2 ml thionyl 
chloride solution. Then added 1 ml of the extract into the test tube and warm, the 
formation of pink color indicates the presence of Triterpenoids. 
Test for Fixed oils and Fats 
(a) Spot Test: - Pressed a small quantity of extract between two filter papers, the 
stain on the filter paper indicates the presence of fixed oils.  
(b) Saponification Test: - Added a few drops of 0.5 N of alcoholic potassium 
hydroxide to small quantity of various extract along with a drop of 
phenolphthalein separately and heat on water bath for 1 to 2 h. The 
formation of soap or partial neutralization of alkali indicates the presence of 
fixed oils and fats. 
 Test for Gums and Mucilage 
 10 ml of ethanolic extract was slowly added to 25 ml of absolute alcohol 
with constant stirring, the precipitate was filtered and dried in air. The precipitate for 
its swelling property indicates the presence of carbohydrates. 
ANIMALS 
A total of 30 Albino Miceand 30 wistar rats with an approximate age of 60 
days were purchased from  
M/s. SreeVenkateshwaraEnterprises  Pvt. Ltd, Bangalore. On their arrival a 
sample of animals was chosen at random and weighed to ensure compliance with the 
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age requested. The mean weights of mice and rats were25 - 30 g and 150-200gm 
respectively.  The animals were housed in metabolic cages (55 x 32.7 x 19 cm), with 
sawdust litter, in such a way that each cage contained a maximum of 5 animals of 
the same sex. 
All animals underwent a period of 7 days of observation and acclimatization 
between the date of arrival and the start of treatment. During the course of this 
period, the animals were inspected by a veterinary surgeon to ensure that they 
fulfilled the health requirements necessary for initiation of the Study. 
They were distributed among the experimental groups using a random 
distribution method. This procedure allows approximate equalization of initial 
bodyweights whilst allowing random allocation to experimental groups. 
ADMINISTRATION ROUTE AND PROCEDURE 
The test substance was administered orally. The mice belonging to the 
control group were treated with the vehicle (distilled water) at the same 
administration volume as the rest of the treatment groups. 
The administration volume for oral administration was 10 ml/kg. The 
quantity of test substance administered to each animal was calculated from its body 
weight on the day of the treatment. 
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INDUCTION OF HEPATOTOXICITY, FREQUENCY AND DURATION OF 
TREATMENT  
Pretreatment Group 
All pretreated groups of albino mice except control groups receives a daily 
dose of Paracetamol (3g/ Kg of body weight) , Silymarin (100mg/kg) and Ethanolic 
Extract of Bauhinia tomentosa Linn (EEBT) (250 and 500mg/kg) for 14 days. 
EXPERIMENTAL DESIGN FOR HEPATOPROTECTIVE ACTIVITY 
Group 1: Receives (Distilled water) as control for 14 days. 
Group 2: Receives a daily dose of Paracetamol (3g/ Kg of body weight, p.o) for 14 
days (p.o) 
Group 3: Receives a daily dose of Paracetamol (3g/ Kg of body weight) and after 
one hour a daily dosage of Standard Silymarin (100mg/kg) of body wieght for 14 
days (p.o) 
Group4:Receives a daily dose of Paracetamol (3g/ Kg of body weight) and one hour 
a daily   dosage of EEBT 250mg / Kg of body weight for 14 days (p.o) 
Group 5:  Receives a daily dose of Paracetamol (3g/ Kg of body weight) and one 
hour a daily   dosage of EEBT 500mg / Kg of body weight for 14 days (p.o) 
Sample collection 
At the end of the 14th day treatment, samples of blood were withdrawn from 
the orbital sinus of mice from each group, under light ether anesthesia after fasting 
for 16 hours. The collected blood samples also centrifuged 10000 rpm in 10 minutes 
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to separate the serum. The separated serum used to evaluate biochemical parameters 
like SGOT, SGPT, ALP and BILIRUBIN. After separation of serum for biochemical 
estimation, the mice were sacrificed, liver of mice were isolated and washed with 
normal saline and stored for 12 h for in vivo antioxidant studies. 
Measurement of Body weight 
The body weight of the animals was monitored daily by weighing on an 
electrical balance with accuracy to ± 0.1 g. All measurements were made every day 
between 8.30 and 9.15 h, immediately before administration of the distilled water in 
the case of control and the drugs paracetamol and thioacetamide (TAA). 
Preparation of tissue homogenate  
 The separated liver  were homogenized with motor driven Teflon coated 
homogenizer with 0.1 M Tris-HCl buffer (pH 7.4) to get 10% homogenate. The 
homogenate was centrifuged at 10000 rpm for 10 min at 5˚C. The supernatant was 
collected and used Antioxidant enzymes viz. Superoxide dismutase (SOD),  Catalase 
(CAT), Glutathioneperoxidise (GPX),  Reduced glutathione (GSH) and Lipid 
peroxidation (LPO) were determined in all the  liver tissues of all the tested mice. 
DETERMINATION OF BIOCHEMICAL PARAMETERS  
Determination of aspartate aminotransferase (AST)/ SGOT 
Aspartate aminotransferase, also known as Serum Glutamate Oxaloacetate 
Transaminase (SGOT)catalyses the transamination of L-aspartate and α keto 
glutarate to form oxaloacetate and L- glutamate. Ox
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with 2,4- Dinitrophenyl hydrazine to form hydrazone, a brown coloured complex in 
alkaline medium which can be measured by colorimetry. 
Reagents  
Buffered aspartate  (pH 7.4); 2,4- DNPH reagent;  4N sodium hydroxide;  
working pyruvate standard; solution I (prepared by diluting 1 ml of reagent 3 to 10 
ml with purified water). 
Procedure  
Rietman and Frankle method was adopted for the estimation of SGOT38.  
The reaction systems used for this study included blank, standard, test (for 
each serum sample) and control (for each serum sample). 0.25 ml of buffered 
aspartate was added into all the test tubes. Then 0.05 ml of serum was added to the 
test group tubes and 0.05 ml of working pyruvate standard into the standard tubes. 
After proper mixing, all the tubes were kept for incubation at 37oC for 60 min, after 
which 0.25 ml each of 2,4- DNPH reagent was added into all the tubes. Then, 0.05 
ml of distilled water and 0.05 ml of each serum sample was added to the blank and 
the serum control tubes respectively. The mixture was allowed to stand at room 
temperature for 20 min. After incubation, 2.5 ml of solution I was added to all test 
tubes. Mixed properly and optical density was measured in a spectrophotometer at 
505 nm within 15 min. 
The enzyme activity was calculated as:-  
AST (GOT) activity in IU/L) = [(Absorbance of test - Absorbance of 
control)/ (Absorbance of standard - Absorbance of blank)] x concentration of the 
standard. 
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Determination of alanine aminotransferase(ALT) or Serum Glutathione 
peroxidase (SGPT) 
Principle 
Alanine aminotransferase is also known as Serum Glutathione Peroxidase 
(SGPT). Itcatalyses the transamination of L-alanine and α keto glutarateinto 
pyruvate and L- Glutamate. The pyruvate so formed is coupled with 2,4 – 
Dinitrophenyl hydrazine to form a corresponding hydrazone, a brown colored 
complex in alkaline medium which can be measured colorimetrically. 
Reagents 
Buffered alanine (pH 7.4), 2,4–DNPH, 4N sodium hydroxide, working 
pyruvate standard, solution I (prepared by diluting 1 ml of reagent 3 to 10 ml with 
purified water). 
Procedure  
Rietman and Frankle method (1957) was adopted for the estimation of 
SGPT.  
The reaction systems used for this study included blank, standard, test (for 
each serum sample) and control (for each serum sample). 0.25 ml of buffered 
alanine was added into all the test tubes. This was followed by the addition of 0.05 
ml of serum into the test group tubes and 0.05 ml of working pyruvate standard into 
the standard tubes. After proper mixing, all the tubes were kept for incubation at 
37oC for 60 minutes, after which 0.25 ml each of 2,4- DNPH reagent was added into 
all the tubes. Then, 0.05 ml of distilled water and 0.05 ml of each serum sample was 
Chapter 5 Materials and Methods 
Dept. of Pharmacology 51 JKK Nattraja College of Pharmacy 
added to the blank and the serum control tubes respectively. The mixture was 
allowed to stand at room temperature for 20 min. After incubation, 2.5 ml of 
solution I was added to all test tubes. Mixed properly and optical density was read 
against purified water in a spectrophotometer at 505 nm within 15 min. 
The enzyme activity was calculated as:- ALT (GPT) activity in IU/L) = 
[(Absorbance of test - Absorbance of control)/ (Absorbance of standard - 
Absorbance of blank)] x concentration of the standard.    
Determination of alkaline phosphatase (ALP)/serum alkaline phosphatase 
(SALP) 
Principle 
Alkaline phosphatase from serum converts phenyl phosphate to inorganic 
phosphate and phenol at pH 10.0. Phenol so formed reacts in alkaline medium with 
4-aminoantipyrine in presence of the oxidising agent potassium ferricyanide and 
forms an orange-red coloured complex, which can be measured spectrometrically. 
The color intensity is proportional to the enzyme activity. 
Reagents:  Buffered substrate 
                 Chromogen Reagent 
                Phenol Standard, 10 mg% 
Procedure: 
ALP was determined using the method of Kind and King39. 
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 The working solution was prepared by reconstituting one vial of buffered 
substrate with 2.2 ml of water. 0.5 ml of working buffered substrate and 1.5 ml of 
purified water was dispensed to blank, standard, control and test. Mixed well and 
incubated at 370C for 3 min. 0.05 ml each of serum and phenol standard were added 
to test and standard test tubes respectively. Mixed well and incubated for 15 min at 
370C. Thereafter, 1 ml of chromogen reagent was added to all the test tubes. Then, 
added 0.05 ml of serum to control. Mixed well after addition of each reagent and the 
O.D of blank, standard, control and test were read against purified water at 510 nm. 
Serum alkaline phosphatase activity in KA units was calculated as follows  [(O.D. 
Test-O.D. Control) / (O.D. Standard- O.D. Blank)] x 10 
Alkaline phosphate was expressed as U/l. 
Determination of bilirubin;  
The bilirubin level in serum was determined by Dangerfield and Finlayson, 
(1953)40. 
Sulfanilic acid reacts with sodium nitrite to produce deoxidized sulfanilic 
acid. Total bilirubin couples with deoxidized sulfanilic acid in the presence of 
methylsulfoxide to produce azobilirubin which may be measured at 532-536 nm. In 
the absence of methyl sulfoxide, only direct (conjugated) bilirubin forms 
azobilirubin complex.   
Reagents  
1. Total bilirubin reagent, Sulfanilic acid, Dimethyl sulfoxide, Stabilizer.  
2. Direct bilirubin reagent, Sulfanilic acid, Preservative. 
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3. Activator, Sodium nitrile.  
4. Artificial standard – 10 mg/dl. 
Procedure 
Estimation of total bilirubin: To 1.0 ml total bilirubin reagent, 0.02 ml of 
activator and 0.1 ml of serum were added, mixed well and incubated for exactly 5 
minutes at room temperature.  
Sample blank was prepared by mixing 1.0 ml total bilirubin reagent with 0.1 
ml of distilled water, mixed well and incubated for exactly 5 minutes at room 
temperature. The absorbance of each sample blank and test were measured at 532-
546 nm against distilled water blank.  Total bilirubin and direct bilirubin level in 
serum was expressed as mg/dl. 
The Bilirubin content was calculated using the following equation: 
Total bilirubin (mg/dt) = Abs of the sample blank x 15. 
Direct Bilirubin(mg/dt) = Abs of sample blank x 10. 
Determination of Total proteins: 
Principle 
This method is a combination of both Folin-ciocalteau and Biuret reaction 
which involves two step reactions. In the first Step Protein binds with copper in 
alkaline medium and reduces it to Cu++. In the second step Cu++ formed catalyses 
the oxidation reaction of aromatic amino acid by reducing 
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Phosphomolybdotungstate to heteropolymolybdanum, which leads to the formation 
of blue colour which is measured at 640 nm.  
Reagents  
Alkaline copper reagent  
Solution A: 2 % w/v of sodium carbonate in 0.1 N NaOH.  
Solution B: 0.5 % w/v copper sulphate in 1 % sodium potassium tartarate 50 ml of 
solution A was mixed with 1 ml of solution B just before use.  (Folin's phenol 
reagent commercial reagent, 1:2 dilutions)  
Procedure  
Lowry method was adopted for the estimation of total protein41.  
To 0.1 ml of the liver homogenate, 0.9 ml of water, 4.5 ml of alkaline copper 
sulphate reagent were added and allowed to stand in the room temperature for 10 
min. To this 0.5 ml of Folin’s reagent was added. After 20 min, the blue colour 
developed was measured at 640 nm.  
The level of protein present was expressed as mg/g tissue or mg/dl.  
Lactate Dehydrogenase Assay 
The method described here is derived from the formulation recommended by 
the IFCC and was optimized for the performance and stability42. 
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Test Principle 
UV Assay 
Lactase dehydrogenase catalyzes the conversion of  L- lactate to pyruvate; 
NAD is reduced to NADH in the process. 
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The initial rate of NADH formation is directly proportional to the catalytic 
LDH activity. It is determined by photometrically measuring the increase in 
absorbance. 
Reagents Working Solutions 
R1   N- Methylglucamine: 400mmol/L, pH 9.4 (37);  
Lithium lactate: 62mmol/L; Stabilizers and Preservatives. 
R2   NAD: 62mmol; Stabilizers and Preservatives. 
Materials Required 
Calibrator, 
Distilled water, 
General laboratory equipment. 
Calculation 
Conversion Factor: U/L X 0.0167 = µkat/L. 
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DETERMINATION OF ANTIOXIDANT ENZYMES AND LIPID 
PEROXIDATION 
1. Determination of superoxide dismutase : 
 Superoxide dismutase scavenges the superoxide radical (O●2) and thus 
provides a first line defence against free radical damage. Superoxide dismutase is an 
endogenous enzymatic antioxidant which catalyzes the dismutation of superoxide 
free radical. This method is based on the inhibition of the spontaneous oxidation of 
the adrenaline to adrenochrome by the enzyme superoxide dismutase.  
 
2H2O + 2O2-  2H2O2 + O2 
Superoxide anion (O2-) interacts with peroxide to form hydroxyl radical 
(OH•) which causes damage in the absence of superoxide dismutase activity (R•) 
Reagents 
Carbonate buffer – 0.05M, pH 10.2: 1.14 g of sodium carbonate and 84 g of 
sodium bicarbonate were dissolved in 100 ml of distilled water. 
Ethylene diamine tetra acetate – 0.49M: 14.3 g of EDTA was dissolved in 
100 ml of distilled water. 
Epinephrine – 3M: 54 mg of epinephrine was dissolved in 100 ml of distilled 
water. 
Procedure 
SOD was estimated as per the procedure described by Kakkaret al43.  
Superoxide dismutase  
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Liver homogenate (0.5 ml) was diluted with 0.5 ml of distilled water. To 
this, 0.25 ml ethanol and 0.15 ml of chloroform, all reagents chilled, were added. 
The mixture was shaken for 1 minute and centrifuged at 2000 rpm. The enzyme in 
the supernatant was determined. To 0.5 ml of the supernatant, 1.5 ml of buffer was 
added. The reaction was initiated by the addition of 0.4 ml epinephrine and change 
in optical density per minute was measured at 480 nm in a double beam UV-VIS 
spectrophotometer (UV 1700,Szhimadzhu)  
SOD activity was expressed as U/mg.  
Change in optical density per minute at 50% inhibition to adrenochrome 
transition by the enzyme is taken as one enzyme unit. 
2. Determination of catalase : 
In animals, catalase is present in all major body organs, especially being 
concentrated in liver and erythrocyte. During β-oxidation of fatty acids by 
flavoprotien dehydrogenase, hydrogen peroxide is generated, which is accepted 
upon by Catalase present in peroxisomes. 
 Catalase catalyses the rapid decomposition of hydrogen peroxide to water.                           
          2H2O2     2H2O + O2 
 
Dichromate in acetic acid was converted to perchloric acid and then to 
chromic acetate when heated in presence of hydrogen peroxide. The chromic acetate 
thus produced is measured spectrophotometrically at 610 nm. The reaction is 
stopped at specific time interval by the addition of dichromate- acetic acid mixture 
and the remaining hydrogen peroxide is determined by measuring chromic acetate. 
Catalase  
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Reagents 
Dichromate-acetic acid reagent: Five % potassium dichromate was prepared 
with acetic acid (1:3 v/v in distilled water). 
Phosphate buffer - 0.01M, pH 7.0: 173 mg of disodium hydrogen phosphate 
and 122 mg of sodium dihydrogen phosphate were dissolved in 200 ml of distilled 
water.  
Hydrogen peroxide – 0.2M: 2.27 ml of hydrogen peroxide was made upto 
100 ml with distilled water. 
Procedure 
The catalase activity was assayed by the method of Sinha (1972)44 
Liver homogenate (0.1 ml) was taken, to which 1.0 ml of phosphate buffer 
and hydrogen peroxide were added. The reaction was arrested by the addition of 0.2 
ml dichromate acetic acid reagent. Standard hydrogen peroxide in the range of 4 to 
20 µl were taken and treated similarly. The tubes were heated in a boiling water bath 
for 10 min. The green color developed was read at 570 nm in a Double beam UV-
VIS spectrophotometer (UV 1700,Szhimadzhu). 
Catalase activity was expressed as U/mg. 
3. Determination of glutathione peroxidase : 
Glutathione peroxidase catalyses the following reaction:  
R-COOH + 2GSH + O2                                            R-CH (OH)-COOH + GSSG + 
H2O 
Glutathione peroxide   
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Glutathione was measured by its reaction with DTNB to give a compound 
that absorbs at 412 nm.  
Reagents 
Sodium phosphate buffer - 0.32M, pH 7.0: 6.96 g of disodium hydrogen 
phosphate and 3.89 g of sodium dihydrogen phosphate was dissolved in 200 ml of 
distilled water. 
Ethylene diamine tetra acetate (EDTA) - 0.8 mM: 233 mg of EDTA was 
dissolved in 100 ml of distilled water. 
Sodium azide-10mM: 6.5 mg of sodium azide was dissolved in 100 ml of 
distilled water. 
Reduced glutathione - 4 mM: 122 mg of glutathione was dissolved in 100 ml 
of distilled water. 
Hydrogen peroxide - 2.5 mM: 0.03 ml of H2O2 was made up to 100 ml with 
distilled water. 
Trichloro acetic acid - 10%: 10 g of TCA was dissolved in 100 ml of 
distilled water. 
Disodium hydrogen phosphate - 0.3 M: 4.25 g of disodium hydrogen 
phosphate was dissolved in 100 ml of distilled water. 
DTNB: 40 mg of 5,5’-dithio bis (2-nitrobenzoic acid) was dissolved in 100 
ml of 1% w/v sodium citrate. 
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Reduced glutathione standard: 20 mg of reduced glutathione was dissolved 
in 100 ml of distilled water. 
Procedure 
The glutathione peroxidase activity was measured according to the method 
of Rotrucket al., (1973)45 
EDTA (0.2 ml each), sodium azide, reduced glutathione, H2O2; 0.4 ml of 
buffer and 0.1 ml of enzyme (liver homogenate) were mixed and incubated at 37°C 
for 10 min. The reaction was arrested by the addition of 0.5 ml of TCA and the tubes 
were centrifuged. To 0.5 ml of supernatant, 3.ml of sodium hydrogen phosphate and 
1 ml of DTNB were added and the color developed was read at 412 nm immediately 
in a Double beam UV-VIS spectrophotometer(UV 1700,Szhimadzhu.) 
Glutathione peroxidase activity, in serum is expressed as µg/mg. 
4. Determination of reduced glutathione : 
DTNB (5, 5’-dithiobis (2-nitrobenzoic acid)), known as Ellman’s Reagent, 
was used for the detection of thiol compounds. DTNB and glutathione (GSH) react 
to generate 2-nitro-5-thiobenzoic acid and glutathione disulfide (GSSG), where 2-
nitro-5-thiobenzoic acid yield a stable yellow colored product, which is proportional 
to GSH concentration, measured at 412 nm. 
Reagents 
10% TCA 0.6 mM 5,5’-dithiobis-2-nitrobenzoic acid (DTNB) in 0.2 M 
sodium phosphate.  
0.2 M Phosphate buffer, pH 8.0  
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Procedure 
Reduced Glutathione was estimated by Ellman’s procedure46. 
To 250 µL of tissue homogenate taken in 2 ml eppendroff tube, 1 mL of 5% 
TCA was added and the above solution was centrifuged at 3000 g for 10 min at 
room temperature. To 250 µL of the above supernatant, 1.5 ml of 0.2 M phosphate 
buffer was added and mixed well. 250 µL of 0.6 mM of Ellman’s reagent (DTNB 
solution) was added to the above mixture and the absorbance was measured at 412 
nm within 10 min. A standard graph was plotted using glutathione reduced solution 
(1 mg/ml) and GSH content present in the tissue homogenates was calculated by 
interpolation. Amount of glutathione expressed as µg/mg protein. 
5. Determination of lipid peroxidation : 
In this method malondialdehyde and other TBARS were estimated by their 
reactivity with thiobarbituric acid TBA) in acidic condition to generate a pink 
coloured chromophore which were read at 535 nm.  
Reagents:  
1. TCA-TBA-HCl reagent: 15% w/v TCA, 0.375 w/v TBA and 0.25 N HCl.  
The solution was heated mildly to assist the dissolution of the TBA.  
2. 0.25 N HCl 
3 .15% TCA  
Procedure  
Lipid peroxidation was estimated by the method of Okhawaet al., (1979)47 
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One ml of liver homogenate was mixed with 0.2 ml 4 % (w/v) sodium 
dodecyl sulfate, 1.5 ml 20% acetic acid in 0.27 M hydrochloric acid (pH 3.5) and 15 
ml of 0.8% thiobarbituric acid (TBA, pH 7.4). The mixture was heated in a hot water 
bath at 85˚C for 1 h. The intensity of the pink colour developed was read against a 
reagent blank at 532 nm following centrifugation at 1200 g for 10 min. The 
concentration was expressed as n moles of MDA per mg of protein using 1,1,3,3,-
tetra-ethoxypropane as the standard.  
HISTOPHATOLOGICAL TECHINIQUES 
Histopathology is the microscopical study of tissues for pathological 
alterations. This involves collection of morbid tissues from biopsy or necropsy, 
fixation, preparation of sections, staining and microscopical examination. 
1) Collection of materials 
         Thin pieces of 3 to 5 mm, thickness were collected from tissues showing gross 
morbid changes along with normal tissue. 
2) Fixation: 
 Kept the tissue in fixative for 24-48 hours at room temperature 
The fixation was useful in the following ways: 
a) Serves to harden the tissues by coagulating the cell protein, 
b) Prevents autolysis, 
c) Preserves the structure of the tissue, and  
d) Prevents shrinkage  
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Common Fixatives: 10% Formalin         
3) Haematoxylin and eosin method of staining: 
Deparaffinise the section by xylol 5 to 10 minutes and remove xylol by 
absolute alcohol. Then cleaned the section in tap water and stained with 
haematoxylin for 3-4 minutes and again cleaned under tap water. Allow the sections 
in tap water for few minutes and counter stained with 0.5% eosin until section 
appears light pink    15 to 30seconds), and then washed in tap water. Blotted and 
dehydrated in alcohol and cleared with xylol( 15 to 30 seconds). Mounted on a 
Canada balsam or DPX Moutant and kept the slide dry and remove air bubbles. 
HEPATOPROTECTIVE EFFICACY OF ETHANOLIC EXTRACT OF 
Bauhinia tomentosa L. ON THIOACETAMIDE INDUCED 
HEPATOTOXICITY IN RAT MODELS 
Thioacetamide 
TAA is an organic compound containing sulfur and white in color. It was 
originally used as a fungicide. It is currently used for the treatment of leather, in labs 
and in the textile and paper industries. 
It can induce acute and chronic hepatic injuries and acts over the synthesis of 
protein, DNA, RNA and over _-glutamyltranspeptidase (GGT) activity48. 
Thioacetamide is bio-activated by the CYP450 and/or by the monooxigenase 
system, which contains flavin, converting the compound into sulfine (a sulfoxide-
type compound) and later into sulfone-type compounds49. Sulfine is responsible for 
generating an increase in the nucleus volume, nucleoli enlargement, an increase in 
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intracellular concentration of Ca+2, generating changes in cellular permeability and 
mitochondrial dysfunction50. On the other hand, Sulfone-type compounds are 
responsible for the liberation of nitric oxide synthase and the nuclear factor kappa B 
(NF-_B), protein denaturalization and lipid peroxidation51. 
INDUCTION OF HEPATOTOXICITY, FREQUENCY AND DURATION OF 
TREATMENT (THIOACETAMIDE) 
Pretreatment Group 
All pretreated groups of albino mice except control groups receives a daily 
dose of thioacetamide 50mg/kg body weight , Silymarin (100mg/kg) and Ethanolic 
Extract of Bauhinia tomentosa Linn (EEBT) (250 and 500mg/kg) for 14 days. 
EXPERIMENTAL DESIGN FOR THIOACETAMIDE INDUCED 
HEPATOTOXICITY 
1. Rats in group I (control group) received the vehicle viz. normal saline (2 
mL/kg) 
2. Rats in group 2 received TAA 50 mg/kgs.c., every 72 h for 21 days. (pre- 
treatment) 
3. Rats in group 3 received Silymarin 100 mg/kg per oral. for 21 days and  
simultaneously administered TAA 50 mg/kg  s.c. 1 h after  the respective 
assigned treatments every  72 h. (pre -treatment) 
4. Rats in group 4 received ethanolic extract of Bauhinia tomentosa Linn. 
(EEBT) extrac of  250 mg/kg p.o. for 21 days and simultaneously 
administered TAA 50 mg/kg s.c. every 72 h. (pre- treatment) 
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5. Rats in group 5 received EEBT 500 mg/kg p.o. for 21 days and 
simultaneously administered TAA 50 mg/kg  s.c. every 72 h. (pre- 
treatment) 
          At the end of the 21st day treatment, samples of blood were withdrawn from 
the orbital sinus of mice from each group, under light ether anesthesia after fasting 
for 16 hours. The collected blood samples also centrifuged 10000 rpm in 10 minutes 
to separate the serum. The separated serum used to evaluate biochemical parameters 
like SGOT, SGPT, ALP and BILIRUBIN. After separation of serum for biochemical 
estimation, the mice were sacrificed, liver of mice were isolated and washed with 
normal saline and stored for 12 h for in vivo antioxidant studies. 
ESTIMATION OF Acid Phosphatase (ACP) 
Principle: 
ACP at an acidic pH hydrolyses αNaphthylphosphate to form αNaphthol and 
inorganic phosphate. The αNaphtholformed is coupled with fast red TR salt to form 
diazo dye complex. The rate of formation of this complex is measured as an increase 
in absorbance which is proportional to the ACP and the testing presence is done to 
find the non-prostatic ACP. The Difference between the activities of the total and 
non-prostatic ACP gives the activity of the prostatic ACP52. 
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Normal Reference Values: 
Serum (Male) : upto 4.2 U/L at 30/ upto 4.7 U/L at 37 
 (Female) : upto 3.0 U/L at 30/ upto 3.7 U/L at 37 
Prostatic ACP : upto 1.5 U/L at 30/ upto 1.6 U/L at 37 
Reagent Preparation: 
Dissolve the substrate in 2.2ml of buffer reagent. Allow the substrate to 
hydrate for around 5 min, then shake and dissolve it. This working reagent is stable 
for at least three days when stored at 2-8. The working reagent may be used for 
the Total ACP assay or the Non- Prostatic ACP Assay as required. 
Procedure: 
Wavelength / Filter : 405nm 
Temperature : 30 / 37 
Light Path : 1 cm 
Calculations: 
ACP Activity in U/L = ∆	/85< = 750 
Prostatic ACP Activity in U/L = Total ACP- Non Prostatic ACP 
Preparation of tissue homogenate  
The separated livers were homogenized with motor driven Teflon coated 
homogenizer with 0.1 M Tris-HCl buffer (pH 7.4) to get 10% homogenate. The 
homogenate was centrifuged at 10000 rpm for 10 min at 5˚C. The supernatant was 
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collected and used Antioxidant enzymes viz. Superoxide dismutase (SOD),  Catalase 
(CAT), Glutathione peroxidise (GPX),  Reduced glutathione (GSH) and Lipid 
peroxidation (LPO) were determined in all the  liver tissues of all the tested rats. 
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RESULTS 
PHYTOCHEMICAL STUDIES 
Extractive value and percentage yield of EEBT 
The nature of the extract obtained following cold maceration with 90% v/v 
of ethanol and percentage yield of leaves of EEBT is shown in Table 2. 
Table2. Percentage yield and nature of EEBT 
 
 Preliminary phytochemical screening of plant extract 
The ethanolic extract of Bauhinia tomentosaLinn whole plant was analyzed 
for the presence of flavonoids, amino acids, tannins, steroids, glycosides and 
reducing sugars, etc., according to standard methods of Harborne et al., (2005); 
Kasture et al., (2003) and Gurudeep et al., (2003). 
  
Plant / Extract Nature of the extract Extraction Yield  (% w/w) 
Ethanol extract of whole plant 
Bauhinia tomentosa L. 
Dark green semisolid 8.34 % 
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Table 3. 
Preliminary phytochemical analysis of Bauhinia tomentosa Linn  
Phytoconstituents Ethanol Extract 
Reducing sugars + 
Glycosides - 
Alkaloids + 
Steroids + 
Flavonoids + 
Proteins - 
Amino Acids + 
Tannins + 
Fixed oils & fats + 
Gum & mucilage - 
Saponins + 
 
+ Present; - Absent 
Phytochemical studies  
Ethanol extract of whole plant of Bauhinia tomentosa Linn. was found to be 
8.34% w/w. The qualitative analysis of the EEBT reveals that the presence of 
flavonoids, reducing sugars, alkaloids, steroids, tannins, saponins, triterpenoids, & 
amino acids. 
Hepatotoxicity is a common side effect of various drugs and xenobiotics. 
Paracetamol is a NSAID which is harmless in normal therapeutic doses and causes 
liver toxicity in high doses in humans. 
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BODY WEIGHT 
Effect of ETHANOLIC EXTRACT OF Bauhinia tomentosa L. on Body Weight 
(Physical Parameter) Analysis on Paracetamol Induced Hepatotoxicity: 
Table 4 
GROUP INITIAL  BODY 
WEIGHT 
FINAL BODY WEIGHT 
 
CONTROL 23.67±0.236 37.333±1.429 
ONLY PARA 33.83±0.543 16.166±5.179* 
PARA + STD 28.00±0.837 16.166±7.231 
PARA + L.D 29.50±0.671 16.000±7.197 
PARA + H.D 31.83±0.910 22.333±7.214 
 
Values are expressed as the mean ± S.D; Statistical significance (p) calculated by one way 
ANOVA followed by dunnett’s ns- no significant  *P< 0.001,  **P < 0.01, ***P < 0.05 calculate by 
comparing treated group with control group. 
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Figure 13 Effect of EEBT on Body weight of albino mice 
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Liver damage is caused when paracetamol is administered to albino mice. 
This is manifested in a lower body weight.  The body weight of normal mice showed 
significantly increased in mice following paracetamol treatment(16.166±5.179). In 
EEBT treated mice at the doses of 250 and 500mg/kg treated mice, the final body 
weights became (16.000±7.197) and (22.333±7.214) respectively.   However, 
administration of paracetamol with standard silymarin and the low dose and high 
dose EEBT significantly reduced the relative body weight. 
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LIVER WEIGHT 
Effect of ETHANOLIC EXTRACT OF Bauhinia tomentosa L. on Liver Weight 
in Paracetamol Induced Hepatotoxicity: 
Table 5 
GROUP LIVER WEIGHT 
CONTROL 0.721±0.236 
ONLY PARA 1.522±0.524 
PARA + STD 1.033±0.463 
PARA + L.D 0.857±0.385** 
PARA +H.D 1.188±0.398* 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by one way 
ANOVA  followed by dunnet’s ns- no significant  *P< 0.001,  **P < 0.01, ***P < 0.05 calculate by 
comparing treated group with CONTROL group. 
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Figure 14: Effect of EEBT on the liver weight of albino mice 
The relative liver weight of the Acetaminophen treated groups shows an 
increase in relative liver weight when compared to the control group. A further 
significant increase in relative liver weight is shown in the Silymarin + 
Acetaminophen treated group (1.033±0.463) when compared to the control group. 
The EEBT treated groups clearly shows a decrease in weight for low dose 250mg/kg 
(0.857±0.385) and a medium increase in relative liver weight at 500mg/kg 
(1.188±0.398) which is the higher dose (HD) administered.  
EFFECT OF ETHANOLIC EXTRACT OF Bauhinia tomentosaLinn  on 
TOTAL BILIRUBIN, DIRECT BILIRUBIN 
Table 6 
GROUP TOTAL BILIRUBIN DIRECT 
BILIRUBIN 
CONTROL 0.958±0.456 0.897±0.237 
ONLY PARA 0.660±0.299 0.970±0.012ns 
PARA + STD 0.503±0.232 0.347±0.064ns 
PARA + L.D 0.440±0.207 0.240±0.021* 
PARA +H.D 0.328±0.206 0.243±0.086* 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by one way 
ANOVA  followed by dunnett’s ns- no significant  *P< 0.001,  **P < 0.01, ***P < 0.05 calculate by 
comparing treated group with control group. 
Bilirubin is an orange-yellow pigment, a waste product primarily produced 
by the normal breakdown of heme. Heme is a component of hemoglobin, which is 
found in red blood cells (RBCs). Bilirubin is ultimately processed by the liver to 
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allow its elimination from the body. Any condition that accelerates the breakdown of 
RBCs or affects the processing and elimination of bilirubin may cause an elevated 
blood level. 
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Figure 15: Effect of EEBT on serum bilirubin 
The above table shows that the levels of bilirubin is decreased in the group 2 
(only paracetamol) (0.660±0.299) and shows gradual decrease on treatment with 
standard drug silimarin, low dose EEBT and high dose EEBT. 
This test shows that there is reduced breakdown of total bilirubin pointing to 
hepato protective activity.  
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         ACTIVITY OF DIRECT BILRUBIN
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Figure 16: Effect of EEBT on direct bilirubin 
Bilirubin that is bound to a certain protein is called unconjugated, or indirect, 
bilirubin. Conjugated, or direct, bilirubin travels freely through the bloodstream to 
the liver. Most of this bilirubin passes into the small intestine. The levels of direct 
bilirubin show significant reduction on treatment with standard drug silymarin and 
low dose EEBT(0.240±0.021) and high dose EEBT(0.243±0.086).  
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EFFECT OFETHANOLIC EXTRACT OF Bauhinia tomentosa Linn. ON 
SERUM PROTEIN IN PARACETAMOL INDUCED HEPATOTOXICITY 
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Figure 17: Effect of EEBT on total serum protein 
Table 7 
GROUP TOTAL PROTEIN 
CONTROL 8.90±0.153 
ONLY PARA 8.60±0.404 
PARA + STD  8.20±1.02 
PARA + L.D 9.87±1.81 
PARA +H.D 9.03±0.463 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by 
one way ANOVA followed by dunnett’s ns- no significant  *P< 0.001,  **P < 0.01, 
***P < 0.05 calculate by comparing treated group with CONTROL group. 
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The level of serum protein which includes albumin and globulin are largely 
unchanged after treatment with paracetamol. The group 3 which received 
paracetamol and standard drug silymarin showed a slight decrease(8.20±1.02) and 
the group 4 (paracetamol + low dose) shows a slight elevation in the level of total 
proteins(9.87±1.81). 
EFFECT OF ETHANOLIC EXTRACT OFBauhinia tomentosa L. ON SGOT, 
SGPT, ALP 
Table 8:  
GROUP SGOT SGPT ALP 
CONTROL 334.5±45.87 61.17±19.92 299.37±54.57 
ONLY PARA 349.7±89.96 42.93±19.61 336.3±27.89 
PARA + STD  271.3±44.92* 34.93±4.313** 356.3±35.41 
PARA + L.D 186.9±60.03** 52.30±22.27 325.9±29.27* 
PARA +H.D 160.4±3.467** 31.67±2.00** 255.8±79.96** 
 
Values are expressed as the mean ± S.D; Statistical significance (p) calculated 
by one way ANOVA  followed by dunnett’s ns- no significant  *P< 0.001,  **P < 
0.01, ***P < 0.05 calculate by comparing treated group with CONTROL group. 
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Figure 18: Effect of EEBT on SGOT and SGPT 
AST – Aspartate amino transferase 
SGOT - Serum Glutamate Oxaloacetate Transaminase 
ALT – Alanineamino transferase 
SGPT - Serum Glutathione peroxidase 
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The level of AST in the paracetamol only group on AST/SGOT shows an 
increase pointing to possible hepatotoxicity (349.7±89.96). The AST levels are 
lowered than the control in the groups 3(paracetamol with std) with an even more 
significant decrease in 250mg/kg  EEBT(186.9±60.03) and 500mg/kg EEBT 
groups(160.4±3.467). This graph shows significant hepatoprotective activity of 
ethanolic extract of Bauhinia tomentosa Linn. 
The level of serum ALT is lower than the control groups of mice in the 
study.  Paracetamol with silymarinstandard(34.93±4.313) and Paracetamol with 
High dose EEBT(31.67±2.00) show comparable levels of hepatoprotectivity.  
In severe tissue damage ALT activity is higher than AST and the ALT:AST 
ratio becomes ≥1(normally <1). Some increase in the activities of ALT and AST are 
seen in extrahepatic cholestasis. In both cirrhosis and carcinoma activity of AST is 
found to be higher than the ALT. ALT is a more liver specific enzyme as increased 
ALT activity in serum is hardly seen in tissues other than liver cell damage.  
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Figure 19: Effect of EEBT on Alkaline phosphatase 
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The mice that were administered only paracetamol showed a higher value of 
alkaline phosphatase than the control (336.3±27.89). The paracetamol and std drug 
silymarin group showed an even higher increase in ALP (356.3±35.41) 
This shows liver damage in these groups. Damaged liver cells release 
increased amounts of ALP into the blood. ALP is especially high in the edges of 
cells that join to form bile ducts. If one or more of them are obstructed, for example 
by a tumor, then blood levels of ALP will often be high. 
The paracetamol and Low Dose EEBT (325.9±29.27)  group showed a slight 
increase in ALP compared to groups 2 and 3. However, paracetamol with High dose 
EEBT showed significant protection from liver damage by registering a lower level 
of ALP than the control groups itself (255.8±79.96). This is a significant find in the 
evaluation of hepatoprotective activity of Bauhinia tomentosa Linn.  
ACTIVITY OF LDH 
Table 9 
GROUP LDH 
CONTROL 2426±325.6 
ONLY PARA 1808±325.6 
PARA + STD  3966±682.9* 
PARA + L.D 1636±65.86** 
PARA +H.D 4158±698.5* 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by 
one way ANOVA followed by dunnett’s ns- no significant  *P< 0.001,  **P < 0.01, 
***P < 0.05 calculate by comparing treated group with CONTROL group. 
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LDH is an enzyme found in all living tissue. Because it is released during tissue 
damage, it is a marker of common injuries and disease.  
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Figure 20: Effect of EEBT on LDH 
LDH: Lactate dehydrogenase 
In our study, we see group 2 mice having a low level of LDH showing the 
pharmacological effect of paracetamol.  Group 3 shows that paracetamol and 
silymarin combination causes marked elevation of LDH. Paracetamol and HD of 
EEBT (4158±698.5)  show marked elevation as well. Paracetamol and low dose 
EEBT lowers Lactate dehydrogenase levels showing significant hepatoprotective 
property. (1636±65.86)  
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EFFECT OFETHANOLIC EXTRACT OF Bauhinia tomentosa L. ON 
HOMOGENISED LIVER TISSUE IN PARACETAMOL INDUCED 
HEPATOTOXICITY 
     Table 10:  
GROUP TOTAL PROTEIN 
CONTROL 0.368±0.164 
ONLY PARA 0.504±0.225 
PARA + STD  0.248±0.111** 
PARA + L.D 0.304±0.136* 
PARA +H.D 0.291±0.131* 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by 
one way ANOVA followed by dunnett’s ns- no significant  *P< 0.001,  **P < 0.01, 
***P < 0.05 calculate by comparing treated group with CONTROL group. 
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Figure 21: Effect of EEBT on homogenized liver tissue 
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Paracetamol and silymarin group and both dosages of EEBT(0.304±0.136), 
(0.291±0.131) lower the protein levels in homogenized liver of albino mice. The 
determination of cellular protein content is very advantageous over other markers 
due to early formation, greater stability and reliability and also their longer life-span. 
EFFECT OF ETHANOLIC EXTRACT OF Bauhinia tomentosa L. ON 
SERUM BIOCHEMICAL MARKERS IN PARACETAMOL INDUCED 
HEPATOTOXICITY 
Table 11 
GROUP SOD CATALASE 
CONTROL 0.107±0.047 0.114±0.053 
ONLY PARA 0.346±0.155 0.393±0.160 
PARA + STD  0.044±0.019** 0.174±0.071* 
PARA + L.D 0.036±0.017** 0.214±0.088** 
PARA +H.D 0.147±0.068* 0.166±0.068** 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by 
one way ANOVA  followed by dunnett’s ns- no significant  *P< 0.001,  **P < 
0.01, ***P < 0.05 calculate by comparing treated group with CONTROL group. 
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Figure 22: Effect of EEBT on SOD and CAT 
SOD: Superoxide dismutase 
CAT: Catalase 
The study shows that silymarin (0.044±0.019), 250mg/kg(0.036±0.017)  and 
500 mg/kg (0.147±0.068) extract lower the levels of Superoxide dismutase enzymes.  
SOD, a key enzyme in free radical protection, increases significantly in the liver 
tissue of group 2 that received only paracetamol(0.346±0.155) suggesting that 
products of free radical reactions are involved in pathogenesis.   A significant 
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decrease offered by the both doses of EEBT shows that the hepatoprotective activity 
of Bauhinia tomentosa Linn. is comparable to standard drug Silymarin.  
Catalase is a common enzyme found in nearly all living organisms exposed 
to oxygen. It catalyzes the decomposition of hydrogen peroxide to water and 
oxygen. It is a very important enzyme in protecting the cell from oxidative damage 
by reactive oxygen species (ROS). Both standard and test doses shows a decline in 
catalase levels (0.214±0.088, 0.166±0.068). 
EFFECT OF ETHANOLIC EXTRACT OF Bauhinia tomentosa Linn. ON 
SERUM BIOCHEMICAL MARKERS IN PARACETAMOL INDUCED 
HEPATOTOXICITY 
Table 12 
GROUP GPX 
CONTROL 0.028±0.013 
ONLY PARA 0.049±0.020 
PARA + STD  0.032±0.015 
PARA + L.D 0.038±0.017 
PARA +H.D 0.035±0.016* 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by 
one way ANOVA  followed by dunnett’s ns- no significant  *P< 0.001,  **P < 
0.01, ***P < 0.05 calculate by comparing treated group with CONTROL group. 
GPx – Glutathione peroxidase 
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The main biological role of GPx is to protect the organism from oxidative 
damage. The biochemical function of glutathione peroxidase is to reduce lipid 
hydroperoxides to their corresponding alcohols and to reduce free hydrogen 
peroxide to water. 
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Figure 23: Effect of EEBT on Glutathione peroxidase 
The mice given paracetamol show marked elevation of GPx levels 
(0.049±0.020). The standard drug silymarin shows a marked reduction of GPx 
activity. The Low dose EEBT (0.038±0.017) and high dose EEBT reduce the level 
of glutathione peroxidase but not as well as the standard drug(0.035±0.016) .  
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EFFECT OF ETHANOLIC EXTRACT OF Bauhinia tomentosa L. on SERUM 
BIOCHEMICAL MARKERS IN PARACETAMOL INDUCED 
HEPATOTOXICITY 
Table 13: LPO assay 
GROUP LPO 
CONTROL 0.102±0.047 
ONLY PARA 0.346±0.155 
PARA + STD  0.044±0.019 
PARA + L.D 0.036±0.017** 
PARA +H.D 0.040±0.019** 
 
Values are expressed as the mean ± S.D; Statistical significance (p)calculated by 
one way ANOVA  followed by dunnett’s ns- no significant  *P< 0.001,  **P < 
0.01, ***P < 0.05 calculate by comparing treated group with CONTROL group. 
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Figure 24: Effect of EEBT on LPO 
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LPO: Lipid peroxidase 
Lipid peroxidation is the oxidative degradation of lipids. It is the process in 
which free radicals "steal" electrons from the lipids in cell membranes, resulting in 
cell damage (0.346±0.155). Paracetamol causes marked elevation of Lipid 
peroxidase in albino mice. The control and the test groups drastically reduce the 
LPO levels showing that the EEBT in both low and high doses (250mg/kg and 
500mg/kg) 0.036±0.017, 0.040±0.019 protect the liver as well as Silymarin in 
paracetamol induced hepatotoxicity.  
EEBT shows promising anti –oxidant, free radical scavenging and anti-lipid 
peroxidase activities.  
EFFECT OF   - ETHANOLIC EXTRACT OF Bauhinia tomentosa L. ON 
HISTOPATHOLOGICAL CHANGES LIVER AFTER 14 DAYS OF 
PARACETAMOL INDUCED HEPATOTOXICITY 
Figure 25:   GROUP-I  CONTROL (VEHICLE) 
   
 10 X 40X 
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SPECIMEN : Liver    
Group – I : Control  
MICROSCOPIC APPEARANCE:  
Section shows liver with normal lobular architecture. The portal tracts show 
normal morphology. The hepatocytes are normal. The sinusoids and central vein 
show normal. There is no inflammation / fibrosis / toxic change.   
Group – II                     :  ONLY PARACETAMOL 
Figure 26: Paracetamol induced toxicity. 
 
 10X 40 X 
SPECIMEN : Liver    
Group – II : ONLY PARACETAMOL 
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MICROSCOPIC APPEARANCE:  
Liver section of paracetamol treated mice showing extensive areas of 
hepatocellular necrosis and inflammatory cell infiltration. Most of the centrilobular 
hepatocytes were swollen with marked cytoplasmic vacuolation and pyknotic nuclei 
with obliterated intervening hepatic sinusoids. The sinusoids show mild dilatation. 
Central veins are congested.  
Figure : 27 GROUP–III- PARACETAMOL + STD 
 
                           10X                                                    40X    
SPECIMEN : Liver    
Group – III : PARACETAMOL + STD 
MICROSCOPIC APPEARANCE:  
Section shows liver with normal lobular architecture. The portal tracts show 
mild inflammation. The hepatocytes are normal. The sinusoids are dilated. The 
central vein show congested. There is no fibrosis / toxic change.  
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GROUP- IV – PARACETAMOL + L.D 
Figure 28: Paracetamol + 250mg/kg EEBT 
   
 10x  40x 
SPECIMEN : Liver    
Group – IV : PARACETAMOL + L.D 
MICROSCOPIC APPEARANCE:  
Section shows liver with normal lobular architecture. The portal tracts show 
mild inflammation. The hepatocytes are normal. The sinusoids are dilated. The 
central vein show congested. There is no fibrosis / toxic change.  
GROUP-V- PARACETAMOL + H.D 
Figure 29: Paracetamol + 500mg/kg EEBT 
   
 10x 40x 
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SPECIMEN : Liver    
Group – V :  PARACETAMOL+ H.D 
MICROSCOPIC APPEARANCE:  
Section shows liver with normal lobular architecture. The portal tracts show 
normal. The hepatocytes are normal. The sinusoids and central veins are normal. 
There is no fibrosis / toxic change/ inflammation.  
Histopathological findings are shown for controls and exposed rats. 
Histopathological findings revealed that the administration of paracetamol resulted 
in necrosis of hepatocytes as well as deposition of fats in the tissues when compared 
with controls, but the severity was reduced in those groups of animals pretreated 
with 100 mg/kg of silymarin, 500 mg/kg and 250 mg/kg of the ethanolic extract of 
Bauhinia tomentosa Linn. 
Group Control Only  Thioacetamide 
Thioacetamide  
+ Std 
Thioacetamide  
+  L.D 
Thioacetamide 
+  H.D 
1st, 
DAY 
134± 
2.129 
139.7± 
2.704ns 
121.8± 
0.9098** 
129.3± 
1.229ns 
126.7± 
0.8028* 
14th  
DAY 
147.8± 
2.197 
150± 
2.933 
143.2± 
1.249 
142.7± 
1.308 
141.3± 
1.202 
21st 
DAY 
165.7± 
1.874 
169.7± 
2.512ns 
152± 
1.414*** 
152.5± 
1.586*** 
153± 
1.528*** 
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EFFECT OF ETHANOLIC EXTRACT Bauhinia tomentosa Linn. On BODY 
WEIGHT in THIOACETAMIDE INDUCED LIVER TOXICITY IN WISTAR 
RATS :- 
 Values are expressed as mean ± SEM Statistical significance (p) calculated 
by one way ANOVA followed by dunnett’s (n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group. Table 14: 
Body weight 
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Figure 31 Effect of EEBT on body weight 1st day 
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   Figure 32 Effect of EEBT on body weight 14th day 
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BODY WEIGHT 21st day
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Figure 33 Effect of EEBT on body weight 21st day 
The body weight increase was more for the TAA only group(139.7±2.704ns)  
than the treated groups. The TAA plus standard dose showed a decrease in weight 
(121.8±0.9098) on the first day. It is highly significant that silymarin (152±1.414 ) 
and Low dose of extract (152.5±1.586) and high dose of extract (153±1.528)  kept 
the body weight lower than the control rats.  
EFFECT OF EEBT ON TAA INDUCED LIVER TOXICITY 
IN WISTAR RAT 
Table 15: Liver weight 
Group Control Only  Thioacetamide 
Thioacetamide  
+ Std 
Thioacetamide  
+  L.D 
Thioacetamide 
+  H.D 
LIVER 
WEIGHT 
(g) 
8.09± 
0.4486 
4.505± 
0.2188*** 
4.814± 
0.3156*** 
4.003± 
0.6874*** 
4.755± 
0.2656*** 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one 
way ANOVA followed by dunnett’s (n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group.  
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Figure 34 Effect of EEBT on liver weight 
The rats that received only TAA showed a marked decrease in liver 
weight4.505± 0.2188. Group 3 that received TAA and standard drug silymrin 
showed a decrease too 4.814±0.3156. The rats that received low dose and high dose 
of EEBT showed a lowered liver weight comparable to the standard group and the 
TAA group with 4.003±0.6874, 4.755± 0.2656respectively.  
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EFFECT OF EEBT ON LIVER ENZYMES IN TAA INDUCED LIVER 
TOXICITY. 
Table 15 
Group Control Only  Thioacetamide 
Thioacetamide  
+ Std 
Thioacetamide  
+  L.D 
Thioacetamide 
+  H.D 
BILIRUBINE 
TOTAL(mg/kg) 
0.7733± 
0.06211 
1.467± 
0.1627*** 
0.7767± 
0.0559ns 
0.89± 
0.01897ns 
0.8067± 
0.08628ns 
SGOT (U/L) 118.3± 
1.142 
230.4± 
4.113*** 
134.7± 
1.774*** 
165.7± 
1.79*** 
167.8± 
1.99*** 
SGPT (U/L) 46.17± 
1.515 
118.4± 
2.436*** 
61.63± 
1.312*** 
71.53± 
1.064*** 
65.27± 
1.571*** 
ALP (U/L) 63.3± 
0.9317 
161.2± 
1.301*** 
72.03± 
1.468*** 
84.3± 
1.554*** 
84.77± 
1.168*** 
ACP (U/L) 2.535± 
1.14826 
6.53333± 
2.96723ns 
3.66667± 
1.66427ns 
4.33333± 
2.01588ns 
5.1± 
2.46293ns 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one 
way ANOVA followed by dunnett’s (n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group.  
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Figure 35 Effect of EEBT on Total bilirubin 
Serum bilirubin showed a very significant increase in the only TAA treated group 
(1.467±0.1627). This shows significant liver damage. This is controlled well by the 
standard silymarin group (0.7767±0.0559) and the Low dose EEBT (0.89±0.01897) 
and the high dose EEBT group0.8067±0.08628ns. This shows marked 
hepatoprotective property of EEBT in both doses.  
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   Figure 36:  Effect of EEBT on SGOT/AST 
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Figure 37:Effect of EEBT on SGPT/ALT 
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Figure 40: Effect of EEBT on ALP 
The level of AST in the TAA only group on AST/SGOT shows an increase 
(230.4±4.113)pointing to possible hepatotoxicity The AST levels are lowered than 
the control in the groups 3(TAA with std).  The low dose EEBT165.7±1.79and High 
dose  EEBT(167.8±1.99) groups showed marked reduction too. This graph shows 
significant hepatoprotective activity of ethanolic extract of Bauhinia tomentosa 
Linn. 
The SGPT/ALT value in TAA treated rat was very high showing high 
hepatotoxicity levels. 118.4±2.436. The standard silymarin TAA group showed 
lowered levels of ALT 61.63±1.312. The LD and HD levels were 71.53±1.064 and 
65.27±1.571 respectively showing the significant hepatoprotective effect of EEBT.  
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Damaged liver releases more ALP into the blood as the TAA treated group shows 
(161.2±1.301). The TAA silymarin group 3 shows a marked reduction of ALP 
72.03±1.468. The HD and LD doses show an equivalent protection level as reflected 
in their respective ALP values. This shows the EEBT to have good hepatoprotective 
properties.  
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Figure 41: Effect of EEBT on Acid phosphatase 
Acid phosphatase level has shot up in the TAA treated wistar rats indicating 
hepatotoxicity of a serious scale. 6.53333±2.96723.  The EEBT extract offers 
protection from the effects of ACP by decreasing the levels in the rat serum.  
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Table 16: Effect on serum Total protein 
Group Control Only  Thioacetamide 
Thioacetamide  
+ Std 
Thioacetamide  
+  L.D 
Thioacetamide 
+  H.D 
TOTAL 
PROTEIN 
(mg/dl) 
0.412833± 
0.185221 
0.591333± 
0.268917 
0.344667± 
0.157663 
0.416± 
0.18979 
0.312± 
0.14022 
 
EFFECT OF EEBT ON THE TOTAL SERUM PROTEIN IN TAA INDUCED 
TOXICITY  
Values are expressed as mean ± SEM Statistical significance (p) calculated by one 
way ANOVA followed by dunnett’s (n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group.  
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Figure 42: Effect of EEBT on total protein 
The serum protein shows increased levels in case of TAA treated group 
0.591333±0.268917. 
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Table 17: Effect of EEBT on SOD, CAT and GPx 
Group Control Only  Thioacetamide 
Thioacetamide  
+ Std 
Thioacetamide  
+  L.D 
Thioacetamide 
+  H.D 
SOD (unit/min/mg 
protein) 
5.8± 
0.2352 
3.117± 
0.1851*** 
6.167± 
0.08433ns 
4.467± 
0.2565*** 
4.767± 
0.09888** 
CATALASE(µmole 
of H2O2 
consumed/min/mg 
protein) 
89.33± 
1.687 
53.33± 
0.9545*** 
90.33± 
1.542ns 
74.33± 
2.642*** 
78± 
0.9661*** 
GPX (µmole of 
glutathione 
oxidized/min/mg 
protein) 
44.5± 
0.922 
22.83± 
0.7032*** 
49.83± 
0.7923** 
34.5± 
1.057*** 
40.83± 
0.7923* 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one 
way ANOVA followed by dunnett’s (n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group.  
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Figure 43: Effect of EEBT on SOD 
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Figure 44: Effect of EEBT on CAT
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Figure 45: Effect of EEBT on GPx (Glutathione peroxidase) 
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Table 18: Effect of EEBT on GSH 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one 
way ANOVA followed by dunnett’s (n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group.  
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Figure 46: Effect of EEBT on GSH (Glutathione) 
The hepatocarcinogen TAA reduces the serum level of anti- oxidants. In 
EEBT treated animals there is a significant increase in the levels of SOD, CAT, GPx 
and GSH compared to controls. The highest concentration of glutathione is in the 
liver, making it critical in the body's detoxification process. EEBT shows significant 
protection against Reactive Oxygen Species. 
Group Control Only  Thioacetamide 
Thioacetamide  
+ Std 
Thioacetamide  
+  L.D 
Thioacetamide 
+  H.D 
GSH 
(µg/mg 
protein) 
32± 
0.5164 
15.83± 
0.7032*** 
38.83± 
0.6009*** 
21.83± 
0.4773*** 
32.33± 
0.6667ns 
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Table 19: Effect of EEBT on LPO 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by one 
way ANOVA followed by dunnett’s (n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group.  
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Figure 46: Effect of EEBT on Lipid peroxidase 
 
Group Control Only  Thioacetamide 
Thioacetamide  
+ Std 
Thioacetamide  
+  L.D 
Thioacetamide 
+  H.D 
LPO 
(nmoles of 
MDA 
formed/mg 
protein) 
9.833± 
0.3073 
 
40.17± 
0.4773*** 
 
15.33± 
0.4216*** 
 
26.5± 
0.5627*** 
 
23.33± 
0.4944*** 
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The Lipid peroxidase level is high in the thioacetamide treated group 
showing significant liver damage(40.17±0.4773).  The silymarin treated group 
shows a good response bringing LPO levels to less than 20moles/mg protein. The 
EEBT treated groups show a decrease of LPO levels 26.5±0.5627 for the Low dose 
and 23.33±0.4944 for high dose extract. This finding is very significant in the 
hepatoprotective activity of the EEBT.  
Treating the cirrhotic animals with low and high dose EEBT significantly 
(P<0.05) increased the levels of SOD and CAT and induced the survival of 
hepatocytes(Table 17). These results collectively supported the suggestion that 
treatment with EEBT could provide a favorable host environment for protecting the 
hepatocytes from progressive damage. 
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EFFECT OF   Ethanolic extract of Bauhinia Tomentosa Linn on Liver of 
Wistar rats 
HISTOPATHOLOGICAL CHANGES 
21 DAYS OF Thioacetamide INDUCED HEPATOTOXICITY 
Group – I : Control  
Figure 47: Thioacetamide study Control 
   
 10x 40x 
SPECIMEN :  Liver    
Group – I     : Control  
MICROSCOPIC APPEARANCE:  
Section shows liver with normal lobular architecture. Individual hepatocytes 
show no pathology.  The portal tracts show normal morphology. The sinusoids and 
central vein show normal. There is no inflammation / fibrosis / toxic change. 
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Group – II : Only Thioacetamide 
Figure 48.Thioacetamide 
   
 10x 40x 
SPECIMEN :  Liver    
Group – II    :  Only Thioacetamide 
MICROSCOPIC APPEARANCE:  
Section from liver shows distorted lobular architecture individual 
hepatocytes shows cytoplasmic vacuolations and binucleation. Portal tracts show 
bile duct hyperplasia and periportal inflammation. Central vein  and sinusoid shows 
mild dilatation.  
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Group – III :  Thioacetamide + STD 
   
 10x 40x 
Figure 49: Thioacetamide + Stdsilymarin 
SPECIMEN  :  Liver    
Group – III   :  Thioacetamide + STD 
MICROSCOPIC APPEARANCE:  
Section from liver shows distorted lobular architecture. Hepatocytes shows 
cytoplasmic vacuolations and binucleation. Portal tracts show bile duct hyperplasia. 
Central vein  and sinusoid shows mild dilatation and congestion.  
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Group – IV :  Thioacetamide + Low dose 250mg/kg 
  
 10x 40x 
Figure 50: Thioacetamide + LD EEBT 
SPECIMEN :  Liver    
Group – IV  :  Thioacetamide + Low dose 250mg/kg 
MICROSCOPIC APPEARANCE:  
Section from liver shows distorted lobular architecture. Hepatocytes show no 
significant pathology. Portal tracts show bile duct hyperplasia and mild periportal 
inflammation. Central vein shows no significant pathology. Sinusoids show mild 
dilatation. 
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Group – V :  Thioacetamide + High dose 500mg/kg 
   
 10x 40x 
Figure 51: Thioacetamide + High Dose EEBT 
SPECIMEN  :  Liver    
Group – V    :  Thioacetamide + High dose 500mg/kg 
MICROSCOPIC APPEARANCE:  
 Section from liver shows normal lobular architecture with interface hepatitis. 
Individual hepatocytes show no significant pathology. Portal tracts show periportal 
inflammation. Central vein and sinusoids show dilatation and congestion. 
The livers of the low dose EEBT(Figure 50) showed less fibrotic macro-
nodules than those of the Silymarin-treated Group III, but the improvements were 
not great as those seen in Groups III and V. These visual evaluations provide further 
independent confirmation that EEBT treatment effectively protected the liver from 
further cirrhosis in a dose dependent manner. 
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SUMMARY AND CONCLUSION 
The present study was designed to evaluate the possible protective effect of 
ethanolic extract of Bauhinia tomentosa Linn (EEBT) against paracetamol and 
thioacetamide induced hepatoxicity in animals.   
A literature survey revealed that more studies were needed for this plant to 
ascertain the hepatoprotective potential. 
The detailed preliminary phytochemical investigations rationalized its use as 
a drug of therapeutic importance. Theethanolic extract of the planthas 
phytoconstituents like flavonoids, terpenoids, sterods, alkaloids, saponins and 
tannins. 
The hepatoprotective effect was assessed using a battery of biochemical and 
histopathological tests. SGOT, SGPT, ALP, LDH, ACP were some of the 
biochemical tests done. In vivo tests for antioxidants (SOD, CAT, GSH, LPO) were 
conducted on albino mice and wistar rats.  
In both paracetamol and thioacetamide induced hepatotoxicity, a lower dose 
and a high dose of extract were used and compared with the hepatoprotective 
activity of standard drug silymarin. Control group and an only drug group were also 
used.  
The EEBT showed marked hepatoprotective activity in lowered levels of 
body weight, positive effect on total bilirubin, total protein and on liver enzymes. 
Histological sections of liver showed that centrilobular necrosis, the pathognomonic 
feature of hepatotoxicity, which appeared in paracetamol-intoxicated mice, was 
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strikingly reduced in EEBT treated mice. Furthermore, the congestion and 
inflammatory cell infiltration evoked by paracetamol was considerably decreased by 
EEBT indicating its possible antihepatotoxic action. 
EEBTethanolic extract has hepatoprotectiveeffects against liver toxicity 
induced by TAA as proven bymacroscopical, microscopical, and biochemical 
analyses. The effects of EEBT are comparable to that of Silymarin, the 
standardhepatoprotective drug. Accordingly, EEBT could beused as an effective 
herbal product for the prevention ofchemical-induced hepatic damage.   
Our results demonstrated that the progression of TAA-induced liver cirrhosis 
could be prevented or reduced using the ethanol extract of Bauhinia tomentosa Linn. 
The plant extract exerted its hepatoprotective effect by preventing the harmful 
cascade of events induced by TAA toxicity. 
In conclusion, we can say that Bauhinia tometosa Linn. has the ability to 
protect the liver from the damaging effects of paracetamol and thioacetamidein toxic 
doses and stimulation of endogenous anti-oxidant defense system. 
In the near future, a further study is warranted to isolate, characterize and 
screen the active components of Bauhinia tomentosa Linn. that have the 
hepatoprotective activity. 
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